Wet age-related macular degeneration

WET_AMD

There were some mistakes of the ICD code for wet-AMD (Exudative senile macular degeneration), the right might as follows: ICD-10 code: H35.32 ICD-9 code: 3625.2

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions not WET_AMD_EARLY	519850
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE>=50 Registry filters: Hospital discharge: ICD-10 — H35.31 Hospital discharge: ICD-9 — 3625B Cause of death: ICD-10 — H35.31 Cause of death: ICD-9 — 3625B 2 out of 7 registries used, show all original rules.	7734
4. Check minimum number of events None	7734
5. Include endpoints None	7734
6. Filter based on genotype QC (FinnGen only)	7529

Control definitions (FinnGen only)

Control exclude: H7_RETINOPATHYDIAB, H7_RETINASEPAR, MACULA_NAS, H7_GLAUCPRIMOPEN, H7_GLAUCCLOSEPRIM, H7_GLAUCSECTRAUMA, H7_GLAUCSECINFLAM, H7_GLAUCSECDISEASE, H7_GLAUCSECDRUG, H7_GLAUCNAS
Control pre-conditions: DEATH_AGE>=50
Control conditions: not WET_AMD_EARLY

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H35
Name in latin: Degeneratio maculae senilis exsudativa

NAME	WET_AMD
CONTROL_EXCLUDE	H7_RETINOPATHYDIAB\|H7_RETINASEPAR\|MACULA_NAS\|H7_GLAUCPRIMOPEN\|H7_GLAUCCLOSEPRIM\|H7_GLAUCSECTRAUMA\|H7_GLAUCSECINFLAM\|H7_GLAUCSECDISEASE\|H7_GLAUCSECDRUG\|H7_GLAUCNAS
CONTROL_PRECONDITIONS	DEATH_AGE>=50
CONTROL_CONDITIONS	!WET_AMD_EARLY
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE>=50
CONDITIONS	!WET_AMD_EARLY
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H3531
HD_ICD_9	3625B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H3531
COD_ICD_9	3625B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Wet age-related macular degeneration based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	55712	35752	19781
Only index persons	52323	33890	18433
Unadjusted period prevalence (%)
Whole population	0.85	1.02	0.55
Only index persons	1.05	1.25	0.70
Median age at first event (years)
Whole population	79.09	80.01	77.43
Only index persons	79.02	79.96	77.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7529	4014	3515
Unadjusted period prevalence (%)	1.51	1.42	1.61
Median age at first event (years)	77.07	77.37	76.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7734: Matched controls
74996

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S01EA05

ATC

brimonidine; ophthalmic

15.1

314.4

285

190

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

4503599627370496.0

307.7

7725

137

S01EE01

ATC

latanoprost; ophthalmic

5.8

307.7

745

1365

ZX198

NOMESCO Finland

Other local administration

64.2

307.7

582

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

49.6

307.7

333

XCW10

NOMESCO Finland

Assessment of vision

23.2

307.7

411

181

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

12.0

307.7

1760

1799

XCK10

NOMESCO Finland

Photography of fundus of eye

6.7

307.7

1992

3705

H25.1

ICD-10 Finland

Senile nuclear cataract

2.7

307.7

4400

24422

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

124.2

307.7

224

XCH00

NOMESCO Finland

Eye pressure measurement

9.2

307.7

1060

1266

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

60.3

307.7

566

H36.01

ICD-10 Finland

Diabetic maculopathy

126.6

307.7

191

H35.7

ICD-10 Finland

Separation of retinal layers

1769.7

307.7

335

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

65.1

307.7

371

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

18.6

307.7

3328

2925

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

196.6

307.7

684

1LA05, ,

NOMESCO Finland

387.5

307.7

380

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

416.7

307.7

5622

476

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

119.3

307.7

463

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

15.0

307.7

316

213

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.3

307.7

5207

28981

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.5

307.7

2397

6831

XCD20

NOMESCO Finland

Photoangiography of eye

60.1

307.7

1094

205

S01EC04

ATC

brinzolamide; ophthalmic

10.0

307.7

459

470

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

15.5

307.7

358

234

ZXA10

NOMESCO Finland

Bilateral

2.9

307.7

2502

10515

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

32.6

307.7

307

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

169.0

307.7

922

S01ED51

ATC

timolol, combinations; ophthalmic

6.9

307.7

959

1509

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

115.6

307.7

287

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

16.8

307.7

3149

2945

H35.6

ICD-10 Finland

Retinal haemorrhage

21.1

307.7

277

132

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

84.3

307.7

317

Z96.1

ICD-10 Finland

Presence of intraocular lens

4.2

307.7

2776

8854

XCW99

NOMESCO Finland

Other investigative procedure of eye

10.9

307.7

2880

3877

114

Kela drug reimbursment

Glaucoma

6.3

307.7

1049

1829

WX140

NOMESCO Finland

Parabulbar anesthesy

4.9

291.6

685

1449

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.0

281.3

1541

5799

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

275.8

4367

26910

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

10.0

273.1

320

321

H26.4

ICD-10 Finland

After-cataract

2.8

272.2

1745

7131

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.2

254.6

3964

23975

H40.11

ICD-10 Finland

Low pressure glaucoma

26.3

240.9

170

CKC12

NOMESCO Finland

Photocoagulation of retina

5.8

235.9

454

801

XCK00

NOMESCO Finland

Perimetry

4.1

230.6

679

1709

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

6.6

213.3

358

551

CKC10

NOMESCO Finland

Local photocoagulation of retina

7.7

207.1

299

390

S01EC54

ATC

brinzolamide, combinations; ophthalmic

21.4

202.0

154

H34.8

ICD-10 Finland

Other retinal vascular occlusions

5.3

200.8

422

806

H3601, E113,

ICD-10 Finland

+∞

194.4

188

H40.9

ICD-10 Finland

Glaucoma, unspecified

17.7

193.9

161

S01EC01

ATC

acetazolamide; systemic

9.0

189.5

239

264

S01ED01

ATC

timolol; ophthalmic

5.4

184.6

382

719

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

167.3

1025

4015

H36.00

ICD-10 Finland

Diabetic background retinopathy

34.1

160.0

104

S01EE03

ATC

bimatoprost; ophthalmic

8.4

158.7

211

249

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

8.0

157.9

219

272

A98

ICPC

Health maint/preventive medicine

2.7

153.7

6973

57846

S01EE05

ATC

tafluprost; ophthalmic

5.4

152.2

313

585

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

3.8

150.3

478

1264

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

18.7

146.1

118

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

5.5

144.2

290

531

H35.36

ICD-10 Finland

Macular cyst

10.3

141.7

161

154

H25.8

ICD-10 Finland

Other senile cataract

2.1

140.7

1629

8392

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.1

140.6

1628

8386

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

+∞

139.4

135

H43.1

ICD-10 Finland

Vitreous haemorrhage

5.2

136.4

290

558

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

5.8

133.7

252

434

S01EE04

ATC

travoprost; ophthalmic

6.8

131.8

211

308

H35.9

ICD-10 Finland

Retinal disorder, unspecified

13.1

129.3

126

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

6.7

129.0

208

306

ZXA05

NOMESCO Finland

Left side

1.9

127.7

2472

15127

S01EX03, ,

ATC

6.5

121.9

203

309

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

7.9

121.6

170

213

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

13.0

121.0

118

H40.0

ICD-10 Finland

Glaucoma suspect

2.8

119.7

654

2397

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

584.3

119.1

119

H35.8

ICD-10 Finland

Other specified retinal disorders

12.5

116.2

116

S01EC03

ATC

dorzolamide; ophthalmic

9.4

116.0

141

148

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.5

115.8

294

656

H3600, E113,

ICD-10 Finland

+∞

113.5

110

CHD00

NOMESCO Finland

Laser trabeculoplasty

15.0

112.2

101

CS494

NOMESCO Finland

Other visual field testing

5.4

111.6

226

416

ZXA00

NOMESCO Finland

Right side

1.8

109.9

2565

16447

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

32.8

101.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

101.7

1071

5262

N02BE01

ATC

paracetamol; systemic, rectal

2.1

99.2

6823

58393

S01BC03

ATC

diclofenac; ophthalmic

4.1

96.9

272

655

XCH05

NOMESCO Finland

Eye pressure longterm registration

12.9

93.0

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

11.3

93.0

1LA01, ,

NOMESCO Finland

+∞

82.5

H44.0

ICD-10 Finland

Purulent endophthalmitis

23.4

81.6

CKC15

NOMESCO Finland

Panretinal photocoagulation

10.5

79.7

F38

ICPC

Eye, Other laboratory test NEC

5.1

79.2

169

326

ZYC01

NOMESCO Finland

Remote contact by phone

2.8

78.8

428

1557

H3603, E113,

ICD-10 Finland

+∞

78.4

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

75.0

5638

46714

Z3231

NOMESCO Finland

Registered nurse

1.6

72.5

2224

14982

H25.0

ICD-10 Finland

Senile incipient cataract

2.1

71.9

717

3426

J01DB01

ATC

cefalexin; oral

1.6

69.1

5822

48966

CKA10

NOMESCO Finland

Biopsy of vitreous body

19.5

68.1

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

67.0

S01BC05

ATC

ketorolac; ophthalmic

2.4

65.8

505

2165

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.1

65.6

279

885

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

310.1

62.7

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

8.2

61.8

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

61.6

4366

34880

S01ED02

ATC

betaxolol; ophthalmic

7.4

59.8

117

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.9

58.9

177

448

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.0

57.9

169

419

C08CA01

ATC

amlodipine; oral

1.5

57.7

3601

27903

H54.1

ICD-10 Finland

Severe visual impairment, binocular

15.7

57.0

1LA04, ,

NOMESCO Finland

101.0

56.1

CKD40

NOMESCO Finland

Endophotocoagulation of retina

4.7

56.1

132

277

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

280.1

55.6

S18

ICPC

Laceration/cut

1.5

55.2

3471

26850

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

54.8

1887

12905

SPAT1263

SPAT

Sampling

1.5

52.8

3153

24086

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

52.7

1883

12965

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

179.0

52.3

CHC05

NOMESCO Finland

Iridotomy

4.8

51.7

119

245

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

496.0

50.9

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

3.8

49.3

152

392

SPAT1301

SPAT

No procedures

1.4

48.1

2651

19846

S01EA03

ATC

apraclonidine; ophthalmic

5.2

48.1

185

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

47.5

3171

24571

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.9

47.3

104

206

H40

ICD-10 Finland

Glaucoma

5.6

47.2

157

SPAT1325

SPAT

Vaccination

1.4

47.0

3003

23077

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

47.0

2754

20834

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

46.9

3991

32251

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

46.4

3816

30630

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.7

46.2

252

917

T90

ICPC

Diabetes non-insulin dependent

1.5

46.0

1918

13577

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

6.0

44.3

129

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

6.1

42.9

120

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

42.8

1870

13331

S01EB01

ATC

pilocarpine; ophthalmic

7.3

41.9

Z71.8

ICD-10 Finland

Other specified counselling

1.5

41.2

1822

13000

H35.3

ICD-10 Finland

Degeneration of macula and posterior pole

16.2

40.4

A02BC02

ATC

pantoprazole; systemic

1.4

40.4

5014

42670

H3601, E103,

ICD-10 Finland

+∞

40.2

L28

ICPC

Limited function/disability (L)

1.5

40.1

1825

13083

H35.37

ICD-10 Finland

Macular holes

3.4

40.0

145

417

H35

ICD-10 Finland

Other retinal disorders

11.0

39.9

H3603, E103,

ICD-10 Finland

+∞

38.1

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.3

37.9

139

CS2P4

NOMESCO Finland

Optic nerve head imaging

6.6

37.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

37.5

2318

17528

SPAT1312

SPAT

General health counselling

1.4

37.4

2123

15814

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

6.4

37.4

H16.0

ICD-10 Finland

Corneal ulcer

2.3

36.4

271

1144

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.3

36.4

213

H44.1

ICD-10 Finland

Other endophthalmitis

12.6

35.3

WX002

NOMESCO Finland

Sedation and analgesia

1.5

35.2

1504

10617

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

35.0

2363

18085

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

34.2

3458

28160

T89

ICPC

Diabetes insulin dependent

2.9

34.1

167

575

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

33.9

550

3076

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

33.9

484

2605

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

33.3

1795

13204

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

10.0

33.0

R42

ICD-10 Finland

Dizziness and giddiness

1.4

33.0

1998

14992

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.4

32.7

224

911

R03AC02

ATC

salbutamol; inhalant

1.3

32.5

3424

27980

M79.6

ICD-10 Finland

Pain in limb

1.4

32.3

2705

21354

AA1AD

NOMESCO Finland

CT of head and brain

1.4

32.2

2441

18977

C10AA01

ATC

simvastatin; oral

1.3

32.0

4090

34330

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

32.0

2946

23583

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

31.6

1528

11008

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

31.4

2207

16940

H81

ICPC

Excessive ear wax

1.4

31.4

1524

10989

WX142

NOMESCO Finland

Sub-tenon anesthesy

5.1

31.0

124

1LA0P, ,

NOMESCO Finland

+∞

30.9

F05

ICPC

Visual disturbance other

2.3

30.3

244

1065

H54.5

ICD-10 Finland

Severe visual impairment, monocular

5.4

30.0

106

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

29.9

H13

ICPC

Plugged feeling ear

1.4

29.0

1605

11817

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.5

28.9

102

289

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

28.9

923

6119

ZXE00

NOMESCO Finland

One hour or less

1.3

28.9

2620

20839

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

+∞

28.8

WZC30

NOMESCO Finland

Teaching

1.5

28.8

1011

6839

UJF32

NOMESCO Finland

Coloscopy

1.4

28.7

2065

15865

SPAT1262

SPAT

Handing over of treatment supplies

1.4

28.5

1356

9722

EBA00

NOMESCO Finland

Extraction of tooth

1.4

28.4

2021

15490

F28

ICPC

Limited function/disability (F)

4.1

28.4

190

J01CA04

ATC

amoxicillin; systemic

1.3

28.3

5242

45963

SPAT1153

SPAT

Removal of sutures

1.3

28.0

2346

18427

H35.1

ICD-10 Finland

Retinopathy of prematurity

47.3

28.0

H91.1

ICD-10 Finland

Presbycusis

1.6

27.9

814

5290

A10AB05

ATC

insulin aspart; parenteral

1.7

27.8

501

2886

SPAT1310

SPAT

Counselling related to known health issue

1.3

27.6

2170

16876

A28

ICPC

Limited function/disability NOS

1.4

27.4

1945

14890

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

141.1

27.3

M54.5

ICD-10 Finland

Low back pain

1.3

27.2

2113

16394

SPAT1216

SPAT

Assessment of functional ability

1.4

27.0

1590

11812

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

27.0

1479

10857

H3600, E103,

ICD-10 Finland

+∞

26.8

H3602, E113,

ICD-10 Finland

+∞

26.8

K02.1

ICD-10 Finland

Caries of dentine

1.3

26.5

2928

23854

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

263.8

26.4

A10AE04

ATC

insulin glargine; parenteral

1.6

26.4

655

4099

L03

ICPC

Low back symptom/complaint

1.4

26.0

1667

12541

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

33.1

26.0

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

8.1

26.0

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

25.9

238

1097

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

25.8

2147

16801

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

25.8

2405

19126

SPAT1254

SPAT

Administration of medicine

1.4

25.5

1354

9875

C10AA05

ATC

atorvastatin; oral

1.3

25.4

3388

28244

CHD35

NOMESCO Finland

Laser goniopuncture

253.6

25.4

H54.4

ICD-10 Finland

Blindness, monocular

7.1

25.2

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

25.1

421

2375

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

25.1

1495

11107

XKD00

NOMESCO Finland

Uroflowmetry

1.4

25.1

1334

9730

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

24.7

2421

19357

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

24.7

H3601, E116,

ICD-10 Finland

+∞

24.7

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.4

24.7

134

H02AB06

ATC

prednisolone; systemic

1.3

24.6

3385

28287

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

24.6

1567

11766

SFA10

NOMESCO Finland

One-surface restoration

1.3

24.6

2844

23249

R06.0

ICD-10 Finland

Dyspnoea

1.3

24.5

2160

17015

B01AF02

ATC

apixaban; oral

1.4

23.8

1284

9375

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

23.8

1811

13959

CKD15

NOMESCO Finland

Injection of vitreous substitute

5.5

23.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

23.6

1844

14263

C07AB07

ATC

bisoprolol; oral

1.3

23.6

4326

37388

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

40.3

23.2

H40.8

ICD-10 Finland

Other glaucoma

40.3

23.2

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

23.2

1882

14635

R06AE07

ATC

cetirizine; oral

1.3

22.9

2484

20081

H54.7

ICD-10 Finland

Unspecified visual loss

3.8

22.9

176

E0000UV, ,

ATC

1.3

22.8

2671

21807

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

22.4

1321

9779

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

22.4

2937

24310

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.1

22.3

149

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

22.3

2128

16903

R02

ICPC

Shortness of breath/dyspnoea

1.4

22.3

1014

7185

J01MA02

ATC

ciprofloxacin; systemic

1.3

22.2

2950

24444

SFA20

NOMESCO Finland

Two-surface restoration

1.3

21.8

2802

23109

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

21.8

2478

20130

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

21.7

1066

7653

R53

ICD-10 Finland

Malaise and fatigue

1.3

21.4

1827

14277

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

21.4

1195

8766

CHD99

NOMESCO Finland

Other filtering operation

213.9

21.3

-1, ,

NOMESCO Finland

1.3

21.3

1584

12138

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

21.2

1993

15780

F93

ICPC

Glaucoma

6.6

21.2

C03CA01

ATC

furosemide; systemic

1.3

21.2

3412

28879

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

21.1

1204

8856

C09CA01

ATC

losartan; oral

1.3

21.0

2038

16204

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

21.0

975

6930

H27.1

ICD-10 Finland

Dislocation of lens

4.2

20.9

131

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

20.9

589

3789

D07AC01

ATC

betamethasone; topical

1.3

20.9

2317

18737

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

48.6

20.8

A04

ICPC

Weakness/tiredness general

1.4

20.6

1178

8668

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

20.4

1188

8767

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

7.0

20.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

20.4

1586

12227

H02

ICPC

Hearing complaint

1.4

20.3

1216

9009

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

20.3

2313

18751

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

20.3

2654

21884

H57.1

ICD-10 Finland

Ocular pain

2.2

20.2

168

745

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

20.0

2005

15989

A10BA02

ATC

metformin; oral

1.3

19.9

2193

17695

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

19.8

665

4442

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

19.8

1065

7756

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

19.4

2064

16573

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

19.3

2755

22916

CKC20

NOMESCO Finland

Cryopexy of undetached retina

7.7

19.2

B01AC04

ATC

clopidogrel; oral

1.3

19.0

1533

11858

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.5

18.9

702

4781

L17

ICPC

Foot/toe symptom/complaint

1.3

18.8

1902

15166

J01AA02

ATC

doxycycline; systemic

1.3

18.5

5327

47804

G04CA02

ATC

tamsulosin; oral

1.3

18.5

2005

16119

H44.2

ICD-10 Finland

Degenerative myopia

7.7

18.4

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

27.0

18.4

A10AE05

ATC

insulin detemir; parenteral

1.7

18.3

317

1806

A10AE06

ATC

insulin degludec; parenteral

2.2

18.3

146

638

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

17.9

2184

17798

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

17.9

2172

17689

SPAT1260

SPAT

Consultation of another employee

1.3

17.8

1244

9420

SPAT1097

SPAT

Recording of ECG

1.3

17.8

1173

8807

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

17.7

141

616

Z01.2

ICD-10 Finland

Dental examination

1.3

17.6

2177

17761

R95

ICPC

Chron obstructive pulmonary disease

1.9

17.5

240

1275

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

17.4

1137

8523

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

4.2

17.4

107

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

17.3

2170

17727

N03AX16

ATC

[U] pregabalin

1.3

17.2

1540

12060

KMAK, ,

NOMESCO Finland

1.2

17.2

2535

21083

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

17.2

804

5710

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.6

17.2

379

2302

A10AA01, ,

ATC

2.8

17.1

286

G04BD12

ATC

mirabegron; oral

1.4

17.1

1006

7422

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.0

17.0

180

878

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

17.0

319

1860

C08CA13

ATC

lercanidipine; oral

1.3

16.9

1206

9157

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

16.9

2833

23889

N06AX11

ATC

mirtazapine; oral

1.3

16.8

2198

18027

C10AA07

ATC

rosuvastatin; oral

1.3

16.5

1982

16088

H3601, E119,

ICD-10 Finland

+∞

16.5

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.3

16.4

119

499

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

16.4

479

3104

CFW99

NOMESCO Finland

Other operation on conjunctiva

34.0

16.4

A10BH05

ATC

linagliptin; oral

1.5

16.3

471

3045

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

16.3

999

7413

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

16.2

333

1988

H35.4

ICD-10 Finland

Peripheral retinal degeneration

3.3

16.2

172

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

16.1

627

4308

A10AB04

ATC

insulin lispro; parenteral

2.4

16.1

108

438

R03BB04

ATC

tiotropium bromide; inhalant

1.4

16.0

849

6154

Z2221

NOMESCO Finland

Medical doctor

1.3

16.0

1738

13931

SPAT1229

SPAT

Assessment of need for aid

1.4

16.0

732

5176

S97

ICPC

Chronic ulcer skin

1.5

16.0

507

3344

R01AD09

ATC

mometasone; nasal

1.2

16.0

2222

18329

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.5

15.9

150

C09AA05

ATC

ramipril; oral

1.2

15.9

2231

18422

SDA03

NOMESCO Finland

Periodontal treatment

1.3

15.8

1758

14131

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

15.8

481

3146

ZXD20

NOMESCO Finland

Day surgery

1.4

15.8

759

5414

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

15.7

889

6515

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.6

15.7

231

3835

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

15.5

1755

14136

H3601, E117,

ICD-10 Finland

+∞

15.4

WX199

NOMESCO Finland

Other local analgesia

1.7

15.4

258

1457

K85

ICPC

Elevated blood pressure

1.3

15.3

1310

10188

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

15.2

1002

7508

RS222, ,

NOMESCO Finland

2.4

15.2

102

414

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.4

15.2

160

UKC02

NOMESCO Finland

Cystoscopy

1.3

15.1

1364

10677

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

15.1

827

6028

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

14.9

517

3473

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

14.8

1191

9178

D07AC13

ATC

mometasone; topical

1.3

14.8

1737

14038

N03AX12

ATC

[U] gabapentin; oral

1.3

14.7

1014

7648

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

14.7

600

4156

G04CB01

ATC

finasteride; oral

1.3

14.7

1034

7821

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

14.7

3826

33561

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.8

14.6

224

1233

SPAT1043

SPAT

Audiometry

1.3

14.6

897

6651

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

14.5

1626

13064

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

14.4

1852

15108

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

14.3

599

4168

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

14.2

370

2338

CK2Z4

NOMESCO Finland

Ocular fundus light imaging (OCT), angiography

35.0

14.2

RS226, ,

NOMESCO Finland

35.0

14.2

Z2446

NOMESCO Finland

Social worker

1.6

14.1

373

2367

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

14.0

1836

15008

A10AB01

ATC

insulin (human); parenteral

2.1

14.0

135

638

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

13.9

1341

10573

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

13.9

1709

13867

A02BC05

ATC

esomeprazole; systemic

1.2

13.9

2609

22133

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

13.9

705

5072

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

13.9

736

5333

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

13.9

1915

15739

CKD60

NOMESCO Finland

Anterior vitrectomy

2.5

13.8

338

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

13.7

1366

10810

R05

ICPC

Cough

1.3

13.7

1376

10903

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

13.7

1660

13447

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

13.6

5464

49760

F29

ICPC

Eye symptom/complaint other

1.4

13.6

517

3535

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

17.0

13.6

N17

ICPC

Vertigo/dizziness

1.3

13.5

969

7343

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

3.5

13.5

124

H01.0

ICD-10 Finland

Blepharitis

1.7

13.4

273

1627

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

4.8

13.4

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

13.4

725

5269

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

73.0

13.4

G04CB02

ATC

dutasteride; oral

1.4

13.4

625

4434

L13

ICPC

Hip symptom/complaint

1.3

13.3

1323

10462

SPAT1234

SPAT

Support of social functional capacity

1.4

13.3

515

3535

M03BX02

ATC

tizanidine; oral

1.2

13.3

3131

27113

CD2S4

NOMESCO Finland

Photography of eye

3.4

13.2

135

M48.0

ICD-10 Finland

Spinal stenosis

1.3

13.2

1049

8065

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

13.1

2444

20687

N30.0

ICD-10 Finland

Acute cystitis

1.3

13.1

1194

9346

C09DA06

ATC

candesartan and diuretics; oral

1.4

13.0

502

3441

R96

ICPC

Asthma

1.4

13.0

578

4066

SPAT1053

SPAT

Memory test

1.2

12.9

1604

13012

M01AH05

ATC

etoricoxib; oral

1.2

12.8

3243

28232

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

12.8

776

5740

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

4.9

12.8

H04AA01

ATC

glucagon; nasal, parenteral

3.1

12.8

158

207

Kela drug reimbursment

Chronic arrhythmias

1.2

12.8

1596

12959

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

12.7

860

6461

H61.2

ICD-10 Finland

Impacted cerumen

1.5

12.7

472

3215

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.4

12.7

478

3264

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

12.6

763

5643

C08CA02

ATC

felodipine; oral

1.3

12.6

880

6646

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

12.6

623

4464

D82

ICPC

Teeth/gum disease

1.2

12.5

1542

12493

DAX08

NOMESCO Finland

Fitting of hearing aid

1.4

12.5

484

3320

J01FA10

ATC

azithromycin; systemic

1.2

12.5

2784

23938

R05

ICD-10 Finland

Cough

1.3

12.5

1270

10069

H40.12

ICD-10 Finland

Pigmentary glaucoma

67.9

12.4

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

12.4

1193

9391

S29

ICPC

Skin symptom/complaint other

1.3

12.4

1237

9784

CKC99

NOMESCO Finland

Other extraocular operations on vitreous body and retina

31.1

12.4

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

12.4

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

12.3

103

461

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.4

12.2

S01EA02

ATC

dipivefrine; ophthalmic

9.0

12.2

H20.8

ICD-10 Finland

Other iridocyclitis

5.0

12.1

H33.2

ICD-10 Finland

Serous retinal detachment

4.8

12.1

C09CA06

ATC

candesartan; oral

1.2

12.0

1438

11608

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

12.0

311

1965

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

12.0

227

1328

SPAT1211

SPAT

Application of soft bandage

1.4

12.0

608

4372

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

12.0

974

7504

R60.0

ICD-10 Finland

Localized oedema

1.3

12.0

984

7592

-44

ICPC

Preventive immunization/medic

1.4

11.9

647

4702

SFA30

NOMESCO Finland

Three-surface restoration

1.2

11.9

2024

16952

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

11.8

2372

20173

B01AB05

ATC

enoxaparin; parenteral

1.2

11.8

2318

19674

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

4.3

11.8

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

2.3

11.8

370

R03DC03

ATC

montelukast; oral

1.3

11.7

773

5791

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.3

11.6

685

5046

A10AC01

ATC

insulin (human); parenteral

1.4

11.6

455

3132

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.5

11.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

11.5

987

7656

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

11.5

528

3737

A03

ICPC

Fever

1.4

11.5

646

4724

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

63.1

11.4

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.8

11.3

152

806

H3601, E1100,

ICD-10 Finland

+∞

11.3

S21

ICPC

Skin texture symptom/complaint

1.3

11.3

921

7095

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.3

11.2

125

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

11.2

1771

14704

K02.2

ICD-10 Finland

Caries of cementum

1.6

11.2

292

1848

N06AX21

ATC

duloxetine; oral

1.4

11.2

560

4018

WX290

NOMESCO Finland

Other blockage of nerve

1.2

11.2

1698

14045

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.6

11.2

259

1596

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.2

955

7403

M01AB05

ATC

diclofenac; systemic, rectal

1.2

11.2

3890

34651

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

11.0

331

2160

R33

ICD-10 Finland

Retention of urine

1.3

11.0

684

5075

H26.2

ICD-10 Finland

Complicated cataract

2.5

11.0

250

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

11.0

1538

12616

SPAT1009

SPAT

Measurement of intraocular pressure

2.3

11.0

363

J05AB01

ATC

aciclovir; systemic

1.2

11.0

1276

10261

S04

ICPC

Lump/swelling localized

1.4

10.8

555

3999

F84

ICPC

Macular degeneration

42.1

10.8

K86

ICPC

Hypertension uncomplicated

1.3

10.7

1005

7879

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

10.6

667

4957

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

10.6

1409

11488

Z46.2

ICD-10 Finland

Fitting and adjustment of other devices related to nervous system and special senses

15.0

10.6

RS221, ,

NOMESCO Finland

2.3

10.6

344

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

10.6

1280

10334

UDC00

NOMESCO Finland

Ear microscopy

1.4

10.5

452

3162

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

10.5

2210

18835

CKD50

NOMESCO Finland

Endodiathermy of retina

8.6

10.5

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

58.3

10.5

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

58.3

10.5

A10BH01

ATC

sitagliptin; oral

1.3

10.5

670

4993

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

10.4

1081

8577

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

10.4

396

2710

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

10.4

696

5221

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

10.4

1244

10033

R5110, ,

SPAT

1.4

10.3

511

3660

G04CA01

ATC

alfuzosin; oral

1.3

10.3

862

6659

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

10.3

717

5406

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

10.3

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

10.3

H3601, H547,

ICD-10 Finland

+∞

10.3

AN1

Coronary angiography

1.3

10.3

1008

7943

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

10.3

886

6874

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

10.2

677

5068

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.3

10.2

686

5145

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

10.2

613

4525

A29

ICPC

General symptom/complaint other

1.3

10.2

925

7223

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

10.2

472

3346

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

10.2

362

2447

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

10.1

609

4498

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

10.1

1150

9221

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.6

10.1

255

1606

R01AD08

ATC

fluticasone; nasal

1.2

10.0

1330

10836

R31

ICD-10 Finland

Unspecified haematuria

1.3

10.0

804

6181

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

10.0

1219

9845

R01AD12

ATC

fluticasone furoate; nasal

1.2

10.0

1150

9232

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.7

10.0

193

1139

SPAT1058

SPAT

PEF monitoring instruction

1.4

9.9

494

3544

J01MA12

ATC

levofloxacin; systemic

1.2

9.9

1317

10736

N05BA04

ATC

oxazepam; oral

1.2

9.8

1712

14329

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.8

934

7336

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

9.8

450

3186

H84

ICPC

Presbyacusis

1.4

9.7

380

2613

CKD20

NOMESCO Finland

Removal of vitreous body substitute

3.3

9.7

102

ZXD05

NOMESCO Finland

Urgent procedure

1.2

9.7

1958

16601

Z00.0

ICD-10 Finland

General medical examination

1.2

9.6

1198

9692

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

9.6

1257

10223

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.6

824

6387

M25.5

ICD-10 Finland

Pain in joint

1.2

9.6

1536

12749

K78

ICPC

Atrial fibrillation/flutter

1.3

9.5

764

5870

K29

ICPC

Cardiovascular sympt/complt other

1.5

9.5

341

2308

R3120

NOMESCO Finland

Training in mobility skills

3.6

9.5

N02AX02

ATC

tramadol; systemic, rectal

1.2

9.5

2871

25167

C01DA14

ATC

isosorbide mononitrate; oral

1.2

9.5

1751

14726

Z5132

NOMESCO Finland

Nursing associate professional

3.1

9.4

119

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.4

9.4

402

2810

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

9.4

854

6666

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

9.4

258

1656

L57.0

ICD-10 Finland

Actinic keratosis

1.3

9.3

992

7886

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

9.3

508

3697

S22.3

ICD-10 Finland

Fracture of rib

1.4

9.3

438

3113

RK320, ,

NOMESCO Finland

2.3

9.3

289

H3601, E118,

ICD-10 Finland

97.1

9.3

3625B

ICD-9 Finland

Other retinal disorders, Degeneration of macula and posterior pole[DEGENERATIO MACULAE EXSUDATIVA]

+∞

9.3

M01AC06

ATC

meloxicam; systemic, rectal

1.2

9.2

2192

18836

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.9

9.2

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

9.2

849

6637

B01AF03

ATC

edoxaban; oral

1.6

9.2

201

1223

U02

ICPC

Urinary frequency/urgency

1.3

9.2

939

7431

Z00.8

ICD-10 Finland

Other general examinations

1.4

9.2

411

2897

L01

ICPC

Neck symptom/complaint

1.3

9.2

770

5951

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.7

9.2

166

963

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

9.2

239

1516

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.2

1308

10730

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.5

9.1

L14

ICPC

Leg/thigh symptom/complaint

1.3

9.1

521

3817

R52.2

ICD-10 Finland

Other chronic pain

1.6

9.1

193

1166

D07AD01

ATC

clobetasol; topical

1.3

9.1

910

7183

A01

ICPC

Pain general/multiple sites

1.3

9.1

611

4584

OAB50, ,

SPAT

1.5

9.1

300

1999

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

9.1

630

4748

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

9.1

792

6152

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

9.0

280

1843

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

2.1

9.0

407

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.7

9.0

164

954

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

9.0

689

5264

M79.1

ICD-10 Finland

Myalgia

1.3

8.9

683

5218

S01KA02

ATC

hypromellose; ophthalmic

1.8

8.9

128

696

A10BK03

ATC

empagliflozin; oral

1.3

8.9

533

3936

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

8.9

577

4310

R51.80

ICD-10 Finland

Headache

1.3

8.8

676

5164

C10AX09

ATC

ezetimibe; oral

1.3

8.8

930

7387

S01BA01

ATC

dexamethasone; ophthalmic

1.6

8.8

193

1177

SCA02

NOMESCO Finland

Preventive oral health care

1.4

8.8

400

2828

H29

ICPC

Ear symptom/complaint other

1.3

8.8

741

5731

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

8.8

430

3078

F99

ICPC

Eye/adnexa disease other

2.6

8.7

190

P20

ICPC

Memory disturbance

1.2

8.7

1441

11986

A10AA02, ,

ATC

1.7

8.7

138

773

C02AC05

ATC

moxonidine; oral

1.4

8.7

337

2318

A46

ICD-10 Finland

Erysipelas

1.2

8.7

1074

8681

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

8.6

301

2028

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

8.6

538

3994

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

8.6

2543

22204

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

8.6

736

5701

S10

ICPC

Boil/carbuncle

1.5

8.6

285

1903

J01FF01

ATC

clindamycin; systemic

1.2

8.6

1523

12751

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

48.5

8.6

A08

ICPC

Swelling

1.4

8.6

397

2816

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

1.8

8.5

115

613

L15

ICPC

Knee symptom/complaint

1.2

8.5

1399

11629

G47.3

ICD-10 Finland

Sleep apnoea

1.2

8.5

988

7933

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.5

8.5

233

1497

A99

ICPC

Disease/condition unspecnature/site

1.3

8.4

602

4554

H30.2

ICD-10 Finland

Posterior cyclitis

4.7

8.4

J45

ICD-10 Finland

Asthma

1.3

8.4

519

3846

S06.0

ICD-10 Finland

Concussion

1.3

8.4

647

4943

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

7.4

8.4

WZC00, ,

SPAT

1.3

8.4

471

3442

D07AB08

ATC

desonide; topical

1.3

8.4

620

4712

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

8.4

611

4636

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

8.4

607

4602

J01CF05

ATC

flucloxacillin; systemic

1.4

8.4

301

2041

RK321, ,

NOMESCO Finland

7.9

8.4

R04.0

ICD-10 Finland

Epistaxis

1.3

8.3

589

4450

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

8.3

628

4786

M15

ICD-10 Finland

Polyarthrosis

1.4

8.3

389

2762

RK322, ,

NOMESCO Finland

6.7

8.3

TQW80

NOMESCO Finland

Local dermatologic skincare

1.6

8.3

165

982

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.3

8.3

532

3967

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

8.3

357

2501

R03BA08

ATC

ciclesonide; inhalant

1.4

8.3

399

2849

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.4

8.2

342

2380

I95.1

ICD-10 Finland

Orthostatic hypotension

1.4

8.2

374

2644

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

8.2

489

3608

ZXE90

NOMESCO Finland

More than 22 hours

2.2

8.2

293

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.3

8.2

504

3736

D11

ICPC

Diarrhoea

1.3

8.2

501

3712

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

8.1

1069

8690

R5120

NOMESCO Finland

Preparation of an aid

1.5

8.1

227

1466

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.8

8.1

136

R52.9

ICD-10 Finland

Pain, unspecified

1.3

8.0

540

4052

R55

ICD-10 Finland

Syncope and collapse

1.2

8.0

892

7122

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

8.0

335

2334

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.6

8.0

185

1143

S82

ICPC

Naevus/mole

1.3

8.0

702

5457

CA1AD

NOMESCO Finland

Orbita CT

4.5

8.0

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.4

8.0

205

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.4

7.9

306

2102

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

3.9

7.9

S19

ICPC

Skin injury other

1.5

7.9

246

1623

U01

ICPC

Dysuria/painful urination

1.3

7.9

462

3401

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.3

7.9

236

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

7.9

747

5860

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.7

7.8

148

870

SPAT1101

SPAT

Orthostatic test

1.4

7.8

421

3060

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.6

7.8

180

1112

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.8

2166

18795

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

1.8

7.8

103

547

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

7.8

1070

8736

I50

ICD-10 Finland

Heart failure

1.4

7.8

340

2389

M01AE02

ATC

naproxen; oral, rectal

1.1

7.8

3086

27481

SPAT1014

SPAT

Treatment of eyes

1.7

7.8

142

828

L08

ICPC

Shoulder symptom/complaint

1.2

7.8

1233

10208

SPAT1281

SPAT

Other administrative function

1.3

7.8

460

3392

H02.1

ICD-10 Finland

Ectropion of eyelid

1.8

7.7

111

605

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

7.7

440

3227

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

7.7

1428

11992

H03AA01

ATC

levothyroxine sodium; systemic

1.2

7.6

1480

12471

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

8.2

7.6

H40.1

ICD-10 Finland

Primary open-angle glaucoma

8.2

7.6

S01FA04

ATC

cyclopentolate; ophthalmic

2.2

7.6

258

J01CA08

ATC

pivmecillinam; oral

1.2

7.6

2629

23173

WW200, ,

SPAT

1.2

7.6

1177

9719

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

7.6

488

3640

H43.3

ICD-10 Finland

Other vitreous opacities

2.1

7.5

329

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.3

7.5

603

4635

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

7.5

142

C09DA01

ATC

losartan and diuretics; oral

1.3

7.4

741

5845

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.3

7.4

218

-31

ICPC

Medical examin/health eval partial

1.3

7.4

468

3483

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

3.4

7.4

H33.5

ICD-10 Finland

Other retinal detachments

2.5

7.4

171

N05CF01

ATC

zopiclone; oral

1.2

7.4

2445

21479

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.0

7.4

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

9.7

7.4

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

7.4

1145

9458

K28

ICPC

Limited function/disability (K)

1.6

7.4

182

1144

H25.9

ICD-10 Finland

Senile cataract, unspecified

1.6

7.3

142

841

CBN20

NOMESCO Finland

Shortening of eyelid retractors

2.0

7.3

346

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

6.0

7.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

7.3

292

2020

CHC03

NOMESCO Finland

Laser iridoplasty

77.7

7.3

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

7.3

661

5155

M02AA07

ATC

piroxicam; topical

1.1

7.3

2594

22895

A11

ICPC

Chest pain NOS

1.3

7.3

550

4195

H34.1

ICD-10 Finland

Central retinal artery occlusion

2.3

7.3

220

M54.3

ICD-10 Finland

Sciatica

1.4

7.3

315

2211

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

7.3

480

3596

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.4

7.2

292

2024

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

7.2

199

1280

N18.8

ICD-10 Finland

Other chronic renal failure

1.5

7.2

193

1234

A10BK01

ATC

dapagliflozin; oral

1.4

7.2

375

2711

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

1.9

7.2

408

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.7

7.2

138

815

H01

ICPC

Ear pain/earache

1.3

7.2

470

3514

H3602, E103,

ICD-10 Finland

+∞

7.2

H3601, E106,

ICD-10 Finland

+∞

7.2

L05

ICPC

Flank/axilla symptom/complaint

1.4

7.2

343

2448

ZX120

NOMESCO Finland

Intravenous

1.3

7.1

575

4422

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

9.1

7.1

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

7.1

3001

26785

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.7

7.1

129

752

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.6

7.1

SFA00

NOMESCO Finland

Small restoration

1.3

7.1

601

4651

L12

ICPC

Hand/finger symptom/complaint

1.2

7.1

809

6478

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

7.1

275

1894

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

1.7

7.1

124

716

H53.4

ICD-10 Finland

Visual field defects

1.7

7.1

129

753

S01BA07

ATC

fluorometholone; ophthalmic

2.0

7.1

351

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

7.0

1146

9506

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.2

7.0

817

6555

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

7.0

226

1503

R06AX22

ATC

ebastine; oral

1.3

7.0

696

5488

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

7.1

7.0

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

7.0

329

2342

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

3.9

7.0

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

1.9

7.0

468

E87.5

ICD-10 Finland

Hyperkalaemia

1.6

7.0

145

875

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.0

1615

13801

R06AX27

ATC

desloratadine; oral

1.2

7.0

1041

8565

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.3

6.9

520

3962

U05

ICPC

Urination problems other

1.3

6.9

377

2746

J01FA09

ATC

clarithromycin; systemic

1.2

6.9

1473

12501

F94

ICPC

Blindness

9.7

6.9

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.7

6.8

132

M01AX05

ATC

glucosamine; oral

1.2

6.8

1687

14489

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

6.8

1600

13689

H31.4

ICD-10 Finland

Choroidal detachment

13.4

6.8

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

6.8

1095

9077

S01BA04

ATC

prednisolone; ophthalmic

1.6

6.7

136

815

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.3

6.7

377

2759

S76

ICPC

Skin infection other

1.4

6.7

305

2159

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

6.7

957

7838

RD211, ,

NOMESCO Finland

1.5

6.7

220

1469

Z72.0

ICD-10 Finland

Tobacco use

1.8

6.7

461

SPAT1360

SPAT

Extensive global examination

1.3

6.7

502

3827

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

6.7

168

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.4

6.7

241

1639

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.3

6.7

198

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.1

6.7

2179

19095

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.3

6.7

403

2983

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.2

6.6

843

6827

DFF15

NOMESCO Finland

Speech audiometry

1.3

6.6

365

2665

K05.30

ICD-10 Finland

Periodontitis complex

1.2

6.6

716

5704

H30.8

ICD-10 Finland

Other chorioretinal inflammations

21.8

6.6

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

6.5

974

8009

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.5

351

2554

A97

ICPC

No disease

1.2

6.5

1081

8979

K59.0

ICD-10 Finland

Constipation

1.3

6.5

415

3095

R06AE09

ATC

levocetirizine; oral

1.3

6.5

535

4126

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.4

6.5

342

2480

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.0

6.5

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

6.5

188

1225

E000006, ,

ATC

1.3

6.5

394

2920

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

6.5

1114

9285

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

7.6

6.5

C09CA03

ATC

valsartan; oral

1.3

6.4

632

4979

B01AF01

ATC

rivaroxaban; oral

1.2

6.4

956

7862

XA421

NOMESCO Finland

Nocturnal polygraphy

3.5

6.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.5

6.4

211

1411

N07BA03

ATC

varenicline; oral

1.7

6.4

109

626

B02

ICD-10 Finland

Zoster [herpes zoster]

1.4

6.4

239

1637

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.2

6.4

742

5954

R4110, ,

SPAT

1.3

6.4

472

3593

S01

ICPC

Pain/tenderness of skin

1.4

6.4

260

1809

3708

FHL

Trabeculectomy or equivalent

67.8

6.3

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.2

6.3

1085

9036

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

6.3

251

1738

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

6.3

1202

10104

J02AC01

ATC

fluconazole; systemic

1.2

6.3

1830

15898

VALMI, ,

NOMESCO Finland

1.2

6.3

1009

8357

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.4

6.3

266

1864

N05AD03

ATC

melperone; systemic

0.3

6.2

592

F32

ICD-10 Finland

Depressive episode

1.5

6.2

167

1072

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

6.2

1361

11572

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.5

6.2

192

1269

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

6.2

530

4108

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

+∞

6.2

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

6.2

F55

ICPC

Eye, Local injection/infiltration

+∞

6.2

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.2

1273

10771

M05BA04

ATC

alendronic acid; oral

1.2

6.2

820

6671

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

6.2

241

1665

S02

ICPC

Pruritus

1.5

6.2

190

1255

S01.0

ICD-10 Finland

Open wound of scalp

1.3

6.1

543

4225

H18.2

ICD-10 Finland

Other corneal oedema

3.5

6.1

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

6.1

288

2052

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.5

6.1

188

1240

CK2M4, ,

SPAT

25.9

6.1

D07XC01

ATC

betamethasone; topical

1.2

6.1

680

5429

R4135

NOMESCO Finland

Rehabilitation for hearing problems

1.5

6.1

161

1029

SPE90

NOMESCO Finland

Other partial denture

1.6

6.1

144

898

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

6.1

542

4222

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

6.1

202

1354

D02

ICPC

Abdominal pain epigastric

1.4

6.1

292

2089

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

3.1

6.1

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.6

6.0

RK110, ,

NOMESCO Finland

2.0

6.0

271

J01EA01

ATC

trimethoprim; systemic

1.1

6.0

1902

16608

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

7116

58701

3.20

178.01

25.3

23.0

4.01

4.00

mmol/l

3.05

6904

56858

(3019550) Sodium [Moles/volume] in Serum or Plasma

7109

58646

3.17

177.09

25.1

22.8

139.42

139.48

mmol/l

0.95

6912

56905

(3010813) Leukocytes [#/volume] in Blood

7144

59167

3.24

175.21

30.5

27.7

7.11

7.02

e9/l

1.89

6882

56749

(3009542) Hematocrit [Volume Fraction] of Blood

7142

59143

3.23

175.16

30.5

27.7

38.44

38.59

0.94

6524

53752

(3000963) Hemoglobin [Mass/volume] in Blood

7143

59168

3.23

174.84

30.8

27.9

129.58

130.13

g/l

2.24

6980

57786

(3007461) Platelets [#/volume] in Blood

7142

59156

3.23

174.82

30.5

27.7

239.10

239.46

e9/l

0.17

6905

57008

(3035941) MCH [Entitic mass]

7142

59158

3.23

174.77

30.4

27.5

30.36

30.39

0.62

6982

57754

(3024731) MCV [Entitic volume]

7142

59161

3.23

174.69

30.4

27.6

91.97

91.91

0.53

6980

57762

(3026361) Erythrocytes [#/volume] in Blood

7142

59161

3.23

174.69

30.5

27.7

4.30

4.31

e12/l

1.06

6878

56742

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6994

57514

2.87

168.78

11.9

11.4

22.56

23.43

u/l

2.64

6614

54548

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6787

55689

2.48

151.42

20.6

18.8

27.10

27.87

mg/l

1.02

5816

46434

(40761511) CBC panel - Blood by Automated count

6786

55736

2.47

149.97

20.3

18.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6416

51727

2.19

143.92

7.4

6.7

42.22

41.01

mmol/mol

17.11

5693

46158

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6556

53539

2.23

138.48

5.6

5.5

2.45

2.51

mmol/l

5.12

5745

47292

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6296

51003

2.06

129.73

19.8

18.3

66.04

68.37

ml/min/173m2

16.56

5298

42223

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6531

53680

2.16

128.59

5.5

5.3

6.20

6.10

mmol/l

7.48

5600

46929

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6285

50940

2.05

128.41

5.3

5.0

2.45

2.11

mu/l

0.46

5513

45014

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6344

51637

2.06

127.38

5.0

4.8

4.34

4.40

mmol/l

3.61

5572

45791

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6265

50990

2.01

122.36

5.0

4.7

1.47

1.46

mmol/l

0.18

5443

44810

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6055

49295

1.88

109.80

4.4

4.2

1.25

mmol/l

0.20

5206

42757

(3031040) Bacteria [#/volume] in Urine by Automated count

5435

42984

1.76

106.66

6.0

5.6

1993.26

1824.34

e6/l

0.08

758

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5809

46872

1.81

106.00

7.5

7.4

81.20

82.30

u/l

0.83

5398

43508

(3013826) Glucose [Moles/volume] in Serum or Plasma

4928

38076

1.70

103.58

4.9

4.7

7.03

6.85

mmol/l

5.75

4644

35781

(3037467) Urinalysis macro (dipstick) panel - Urine

5384

42657

1.74

102.73

5.4

5.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5398

43130

1.71

96.07

4.7

4.3

16.65

15.79

mm/h

3.06

4846

38958

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5239

41883

1.66

89.13

4.3

4.0

15.40

15.25

pmol/l

3.69

4545

36722

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4545

35301

1.60

84.71

6.8

6.4

1.21

1.22

mmol/l

1.98

3734

29599

(3022217) INR in Platelet poor plasma by Coagulation assay

4461

34739

1.58

80.07

22.1

21.1

1.47

1.40

inr

0.38

1353

9209

(3002385) Erythrocyte distribution width [Ratio]

5521

45372

1.63

77.49

24.2

22.2

15.60

15.61

0.04

5406

44365

(3044889) 12 lead EKG panel

5064

40769

1.59

77.40

4.9

4.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3402

25040

1.57

77.08

3.4

3.3

2103.36

2002.28

ng/l

0.54

2951

21790

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4245

33244

1.53

69.76

5.2

5.7

11.83

12.46

umol/l

2.57

3988

31311

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4095

31971

1.51

67.16

6.1

5.7

1.21

mmol/l

1.35

3640

28594

(3009261) Glucose [Presence] in Urine by Test strip

3877

29992

1.51

65.96

4.8

4.5

0.00

estimate

0.31

770

5211

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3604

27515

1.51

64.97

4.8

4.4

83.43

88.08

ng/l

0.06

2957

21910

(3026008) Bacteria identified in Urine by Culture

3335

25055

1.51

64.96

3.8

—

(3035350) Ketones [Presence] in Urine by Test strip

3834

29698

1.50

64.07

4.8

4.5

0.00

estimate

1.90

857

5827

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3884

30173

1.50

63.94

2.3

2.2

92.21

92.97

pmol/l

0.41

1987

15253

(3021601) Nitrite [Presence] in Urine by Test strip

3820

29590

1.50

63.68

6.2

6.0

0.00

estimate

0.50

773

5230

(3013650) Neutrophils [#/volume] in Blood by Automated count

4237

33552

1.50

63.16

7.6

8.2

4.59

4.41

e9/l

4.17

3689

28700

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3154

23614

1.50

61.31

3.3

2.9

145.84

155.98

ug/l

1.07

2747

21012

(40760892) CBC W Ordered Manual Differential panel - Blood

3478

26590

1.49

60.81

5.9

6.0

—

(3013115) Eosinophils [#/volume] in Blood

3785

29496

1.48

59.70

5.5

0.21

0.20

e9/l

1.74

3272

25061

(3021589) Normoblasts [#/volume] in Blood

3253

24614

1.49

59.42

11.2

10.6

0.00

e9/l

0.90

2683

19800

(3006315) Basophils [#/volume] in Blood

3691

28656

1.48

59.10

5.3

0.04

e9/l

1.12

3159

24031

(3019198) Lymphocytes [#/volume] in Blood

3742

29172

1.47

58.40

5.4

1.80

1.88

e9/l

1.32

3273

24998

(3001604) Monocytes [#/volume] in Blood

3672

28526

1.47

58.32

5.3

0.65

0.63

e9/l

2.69

3130

23912

(3002030) Lymphocytes/100 leukocytes in Blood

3548

27539

1.46

55.61

5.9

24.30

25.26

5.12

3259

25250

(3019069) Monocytes/100 leukocytes in Blood

3502

27137

1.46

55.23

6.0

8.96

8.94

0.11

3222

24838

(3024561) Albumin [Mass/volume] in Serum or Plasma

3821

30140

1.45

54.65

4.5

4.4

33.95

34.20

g/l

1.90

3438

27444

(3018010) Neutrophils/100 leukocytes in Blood

3487

27050

1.46

54.38

5.6

60.33

59.33

4.60

3209

24793

(3006504) Eosinophils/100 leukocytes in Blood

3477

27000

1.45

53.68

5.6

5.7

2.86

2.80

0.76

3193

24675

(3020682) Albumin/Creatinine [Ratio] in Urine

2781

20692

1.47

53.65

3.8

3.6

11.56

9.31

mg/mmol

1.42

1732

12704

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2581

18966

1.48

52.83

2.6

2.3

3.28

3.20

mg/l

0.67

2154

15948

(3012516) Albumin [Mass/volume] in Urine

2634

19449

1.48

52.55

3.3

3.1

414.44

357.54

mg/l

0.25

1663

12204

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3867

30733

1.44

52.12

3.2

3.1

54.17

56.57

u/l

0.72

3422

27279

(3022096) Basophils/100 leukocytes in Blood

3381

26234

1.44

51.75

5.6

0.64

0.63

0.25

3099

23969

(3023368) Bacteria identified in Blood by Culture

2796

21012

1.45

50.34

4.2

—

(3009508) Creatinine [Moles/volume] in Urine

2631

19556

1.46

50.12

3.2

3.0

6.45

6.71

mmol/l

2.85

2070

15832

(3021960) Folate [Moles/volume] in Serum or Plasma

2476

18301

1.46

48.08

1.7

1.6

20.46

20.21

nmol/l

0.29

2025

15360

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3263

25407

1.42

47.64

2.3

2.2

82.17

80.64

nmol/l

2.17

2741

21715

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1823

12788

1.50

45.66

1.9

—

(3018095) Leukocytes [#/volume] in Urine

3072

23805

1.42

45.37

4.4

4.1

140.74

140.98

e6/l

0.00

2307

17324

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2901

22298

1.42

44.65

5.2

5.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2618

19772

1.43

44.39

2.5

61.95

64.63

u/l

0.22

2380

18023

(3002582) Erythrocytes [#/volume] in Urine

2766

21102

1.42

44.31

3.8

3.6

250.12

91.99

e6/l

1.13

2177

16345

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3026

23677

1.39

40.91

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3011

23595

1.39

40.09

2.9

3.2

2.35

2.36

mmol/l

0.90

2536

19840

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2743

21163

1.40

40.07

2.2

2.1

240.76

220.18

u/l

0.41

2532

19592

(3029937) Albumin [Presence] in Urine by Test strip

2192

16321

1.42

39.09

5.2

4.9

0.00

estimate

0.15

733

4988

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2096

15542

1.42

38.04

1.8

1.7

8238720.12

24151847.77

pmol/l

1.58

1578

12285

(3030467) Casts [#/volume] in Urine by Automated count

2523

19375

1.39

37.17

3.6

3.5

0.47

0.53

e6/l

0.77

1984

15019

(3041096) Erythrocytes [Presence] in Urine by Automated

1993

14710

1.42

36.92

4.5

4.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1613

11452

1.46

36.84

2.8

2.4

10.89

11.54

umol/l

3.29

1459

10408

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3469

28108

1.36

36.22

2.9

2.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2246

16982

1.40

36.04

1.8

1177.90

1166.31

nmol/l

0.22

1583

12479

(3015736) pH of Urine

3026

24023

1.36

35.94

4.3

4.2

6.01

5.85

0.76

641

(3013512) EKG study

2613

20300

1.37

35.44

4.8

4.7

—

(3018418) pH of Serum or Plasma

2702

21123

1.37

35.17

4.1

3.9

7.40

1.38

553

3812

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1504

10622

1.46

35.08

2.8

2.4

2.23

2.26

g/l

1.08

1343

9623

(36304419) Bacteria [Presence] in Urine

2390

18421

1.37

33.62

3.6

3.5

—

(3000850) Epithelial cells [#/volume] in Urine

2000

14987

1.40

33.32

2.9

2.8

4.89

5.27

e6/l

0.80

1762

13366

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1429

10102

1.46

32.91

2.9

2.5

19.74

20.58

1.47

1167

8374

(40768804) Tissue Pathology biopsy report

2879

22990

1.34

31.69

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2612

20562

1.35

31.60

6.0

5.7

4.59

4.56

ug/l

0.01

2285

17969

(3026782) Osmolality of Urine

1936

14626

1.38

30.17

3.3

3.2

517.89

534.40

mosm/kgh2o

3.27

1634

12483

(3007853) Bacteria identified in Skin by Aerobe culture

1073

7293

1.50

29.90

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1251

8912

1.43

27.08

1.9

1.8

—

(3003338) MCHC [Mass/volume]

4900

42685

1.31

26.92

28.7

25.5

329.61

330.13

g/l

3.70

4855

42074

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

887

5943

1.51

26.28

3.3

3.8

1.22

1.23

mmol/l

2.01

725

5106

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1241

8892

1.42

25.91

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1663

12579

1.36

24.95

1.7

1.60

1.59

mg/l

0.03

1300

9836

(3023520) Reticulocytes [#/volume] in Blood

1025

7139

1.45

24.90

2.3

2.4

67.64

67.46

e9/l

0.06

779

5435

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2092

16477

1.32

23.61

2.9

3.0

35.86

35.87

u/l

0.00

1946

15339

(3027945) Reticulocytes/100 erythrocytes in Blood

1294

9491

1.39

23.34

2.2

1.80

1.78

0.30

1094

8199

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1012

7133

1.43

22.92

4.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1864

14498

1.33

22.87

2.9

3.1

2.47

mmol/l

0.04

1615

12383

(3026493) Urate [Moles/volume] in Serum or Plasma

2025

15947

1.31

22.70

2.9

8069.77

7099.64

umol/l

0.31

1677

13254

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1018

7274

1.41

21.25

2.6

2.5

5.40

6.02

ug/l

0.77

807

6015

(40761536) Microorganisms panel - Urine sediment

741

4992

1.49

21.18

4.9

4.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1766

13791

1.31

20.72

1.6

1.28

mmol/l

0.05

1390

11286

(3002032) Base excess in Venous blood by calculation

1001

7212

1.40

19.83

3.8

3.4

1.93

2.03

mmol/l

0.41

819

6092

(3025159) Blasts/100 leukocytes in Blood

672

4497

1.49

19.81

3.7

3.8

0.14

0.39

1.36

192

1382

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2052

16428

1.29

19.80

4.9

22.39

22.32

0.07

1173

8997

(3012544) pH of Venous blood

1030

7467

1.39

19.65

3.7

3.4

7.39

—

(1761868) Lipid panel - Serum or Plasma

1628

12662

1.31

19.50

3.7

3.5

—

(3044640) Blood type and Crossmatch panel - Blood

2498

20525

1.27

19.44

2.8

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

741

5083

1.46

19.25

3.7

0.96

0.94

0.07

251

1925

(3042936) Bacteria identified in Isolate by Culture

1221

9134

1.35

19.09

2.0

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

998

7230

1.39

19.09

3.7

3.4

5.78

5.85

kpa

1.26

967

6996

(40758558) Short blood count panel - Blood

1876

14910

1.29

19.02

6.0

6.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

708

4828

1.46

18.96

3.7

3.8

0.12

0.10

0.20

222

1683

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

728

5003

1.45

18.72

1.8

1.7

—

(3016502) Oxygen saturation in Arterial blood

1054

7730

1.37

18.67

5.9

6.1

94.61

95.21

1.85

1019

7377

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1463

11324

1.31

17.96

3.3

3.2

2.64

3.10

e6/l

0.87

858

6333

(3002179) Metamyelocytes/100 leukocytes in Blood

668

4579

1.45

17.37

3.6

3.7

0.82

0.67

0.50

217

1635

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1162

8741

1.34

17.37

3.3

3.7

244.46

250.91

u/l

0.84

1084

8124

(3009343) pH of Capillary blood

666

4566

1.45

17.31

3.5

3.7

7.41

7.42

0.88

585

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1806

14432

1.28

17.27

5.1

4.3

334.53

416.90

ng/l

0.32

1614

12845

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1545

12117

1.30

17.09

3.1

3.0

1.13

1.36

e6/l

1.89

925

7067

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

672

4630

1.45

17.00

3.6

3.7

5.15

5.16

kpa

0.12

614

4324

(3003396) Base excess in Arterial blood by calculation

1152

8690

1.34

16.86

5.8

1.24

1.23

mmol/l

0.02

897

6773

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1208

9185

1.33

16.73

5.4

4.8

1.07

1.04

mmol/l

3.22

1107

8268

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

645

4424

1.45

16.71

3.5

3.6

1.91

2.11

mmol/l

0.60

447

3277

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1470

11495

1.30

16.57

3.4

0.84

0.86

ug/l

0.39

1094

8510

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1150

8718

1.33

16.22

5.8

5.03

5.06

kpa

0.50

1084

8207

(3027801) Oxygen [Partial pressure] in Arterial blood

1149

8714

1.33

16.15

5.8

11.23

11.75

kpa

2.90

1082

8191

(3011397) Hemoglobin [Presence] in Urine by Test strip

1851

14939

1.26

16.13

4.7

4.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

657

4611

1.42

14.98

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1265

9831

1.30

14.77

1.2

1.51

1.73

u/ml

0.32

312

2240

(3024354) Oxygen [Partial pressure] in Venous blood

822

6016

1.36

14.57

3.2

2.9

4.44

4.33

kpa

0.67

793

5798

(3007164) IgA [Mass/volume] in Serum or Plasma

1116

8560

1.31

14.34

1.4

1.5

2.84

2.71

g/l

0.69

615

4500

(40768797) Stomach Pathology biopsy report

1060

8086

1.31

14.17

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

928

6956

1.33

14.03

6.4

6.5

117.08

118.75

g/l

1.81

911

6738

(3019150) Specific gravity of Urine by Refractometry

1677

13590

1.25

13.78

5.5

5.0

1.01

1.02

kg/l

1.49

282

2208

(3019060) Gas panel - Arterial blood

713

5156

1.38

13.60

4.6

4.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1116

8630

1.30

13.44

9.6

8.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1376

10939

1.27

13.27

2.0

1.9

30.29

30.10

0.52

1332

10582

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1885

15541

1.23

13.13

2.7

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

703

5108

1.37

13.01

1.9

190.23

172.98

ug/g

0.35

514

3893

(3008152) Bicarbonate [Moles/volume] in Arterial blood

665

4809

1.37

12.67

7.1

6.1

24.36

24.62

mmol/l

0.94

638

4551

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

756

5589

1.35

12.50

1.7

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1368

10941

1.26

12.46

2.6

0.82

0.81

mmol/l

1.49

1247

9981

(3004588) Protein electrophoresis panel - Serum or Plasma

753

5601

1.34

11.93

2.2

2.3

—

(3019225) pH of Specimen

964

7429

1.30

11.83

4.9

4.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

851

6456

1.31

11.73

6.7

5.6

12.19

11.63

mmol/l

1.17

789

6027

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

556

3958

1.39

11.65

1.5

1.6

1.59

1.58

g/l

0.13

464

3353

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

468

3236

1.43

11.60

2.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

405

2730

1.46

11.50

3.8

4.2

24.81

24.98

mmol/l

0.48

357

2437

(3020630) Protein [Mass/volume] in Serum or Plasma

871

6663

1.30

11.28

2.4

65.69

65.59

g/l

0.13

763

5831

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

568

4083

1.38

11.22

2.6

2.5

—

(3022145) Colonoscopy Study observation

804

6097

1.31

11.10

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

775

5848

1.32

11.09

3.6

3.4

109.13

95.08

ng/l

2.41

623

4823

(4200892) Spirometry reversibility

578

4183

1.37

10.95

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

642

4727

1.35

10.88

3.3

3.1

125.34

126.05

g/l

0.36

628

4612

(3022313) Gas panel - Capillary blood

464

3254

1.41

10.63

3.6

3.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

993

7785

1.27

10.58

3.4

3.1

260.85

260.98

ng/l

0.00

907

7127

(3000991) Gas panel - Venous blood

797

6090

1.30

10.39

6.3

6.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

554

4018

1.36

10.36

3.5

3.3

24.86

25.25

mmol/l

1.58

535

3918

(3007930) Methemoglobin/Hemoglobin.total in Blood

457

3222

1.40

10.16

4.5

0.85

0.86

0.20

438

3018

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

468

3314

1.39

10.14

1.8

2.63

2.44

ug/l

0.11

384

2825

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

429

2995

1.41

10.10

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1008

7962

1.26

10.06

1.3

39.91

41.43

iu/ml

0.12

350

2424

(3022621) pH of Urine by Test strip

611

4539

1.33

9.75

3.9

3.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

871

6785

1.28

9.75

2.5

8.51

9.96

umol/l

1.34

766

5813

(3014111) Lactate [Moles/volume] in Serum or Plasma

836

6481

1.28

9.73

5.2

5.5

1.43

1.41

mmol/l

0.19

800

6266

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

476

3408

1.38

9.66

4.6

3.5

23.96

24.22

mmol/l

1.04

462

3295

(40767503) Oxygen content in Capillary blood by calculation

250

1589

1.54

9.48

2.5

15.40

15.65

0.40

130

845

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

542

3973

1.35

9.47

5.7

5.9

24.82

24.98

mmol/l

0.42

535

3920

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

289

1905

1.49

9.24

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

457

3275

1.38

9.23

4.5

1.57

1.55

0.18

442

3067

(3034860) Kappa light chains.free [Mass/volume] in Serum

396

2771

1.41

9.22

2.6

2.9

56.61

90.90

mg/l

0.82

317

2246

(46235355) HIV 1 and 2 tests - Meaningful Use set

549

4055

1.34

9.12

1.6

1.4

—

(3010421) pH of Blood

284

1871

1.49

9.11

4.2

7.42

0.70

256

1688

(3030981) Hyaline casts [#/volume] in Urine by Automated count

525

3856

1.34

9.06

3.1

2.9

0.32

0.33

e6/l

0.08

517

3780

(3036481) Cortisol [Moles/volume] in Serum or Plasma

642

4853

1.31

9.05

1.9

2.1

374.39

386.36

nmol/l

0.66

567

4331

(3018405) Lactate [Moles/volume] in Arterial blood

385

2695

1.41

8.95

4.3

3.6

1.45

1.44

mmol/l

0.05

380

2643

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

393

2766

1.40

8.86

2.6

2.9

97.65

50.97

mg/l

1.17

315

2242

(40761535) Cells panel - Urine sediment

776

6038

1.27

8.75

4.0

3.7

—

(3025941) Bacteria identified in Stool by Culture

401

2838

1.39

8.75

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1851

15759

1.18

8.60

4.1

3.9

82.26

82.45

0.11

1807

15363

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

381

2690

1.39

8.44

2.6

2.9

1.91

2.71

ratio

0.40

196

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

731

5676

1.27

8.38

2.3

36.10

36.93

u/l

0.09

596

4799

(3045414) Leukocytes [Presence] in Urine

387

2745

1.39

8.34

2.4

2.0

—

(1616796) Gas panel - Central venous blood

254

1672

1.49

8.22

3.5

3.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

934

7477

1.24

8.22

1.2

21.53

16.90

u/ml

0.65

316

2384

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

244

1593

1.50

8.22

2.3

2.1

179.17

87.73

ug/min

1.45

143

889

(3000330) Specific gravity of Urine by Test strip

537

4016

1.32

8.19

4.2

4.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

361

2541

1.40

8.15

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1555

13094

1.19

8.15

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

261

1733

1.48

8.10

2.6

2.8

7.66

7.71

kpa

0.25

250

1690

(3002256) Pathology report gross observation

988

7971

1.23

8.08

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

499

3704

1.33

8.03

2.3

2.7

10.89

10.58

g/l

0.62

454

3333

(3037522) Nuclear Ab [Titer] in Serum

769

6044

1.26

7.96

1.3

502.35

511.40

titre

0.05

179

1409

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

290

1975

1.44

7.90

1.5

1.6

—

(3049717) Cytology report of Urine Cyto stain

441

3225

1.35

7.86

2.7

2.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

248

1643

1.48

7.80

4.1

4.3

5.06

5.02

kpa

0.27

241

1589

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

599

4581

1.29

7.75

6.9

7.1

1.39

1.33

1.02

592

4542

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

465

1.91

7.75

1.1

2.14

2.49

iu/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

501

3746

1.32

7.67

1.6

1.4

—

(3012501) Base excess in Blood by calculation

247

1642

1.47

7.64

4.1

4.3

2.68

2.91

mmol/l

0.61

179

1132

(3027315) Oxygen [Partial pressure] in Blood

248

1652

1.47

7.60

4.1

4.3

8.26

8.23

kpa

0.09

241

1597

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

595

4569

1.28

7.46

7.0

7.2

0.65

0.68

0.79

589

4531

(3028026) IgM [Mass/volume] in Serum or Plasma

404

2941

1.35

7.43

1.9

1.8

1.63

1.42

g/l

0.51

356

2580

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

972

7896

1.22

7.42

5.1

4.9

35.00

34.15

1.43

599

4974

(3028271) Lactate [Moles/volume] in Capillary blood

185

1165

1.55

7.41

1.9

1.64

1.67

mmol/l

0.20

178

1136

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

366

2626

1.37

7.39

2.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

212

1379

1.50

7.32

1.7

1.5

0.66

8.99

iu/ml

1.48

372

(3020891) Body temperature

409

2997

1.34

7.21

5.1

4.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

296

2059

1.41

7.20

2.4

3.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

162

1005

1.58

6.95

2.0

2.1

30.49

28.18

mg/l

0.14

239

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

430

3202

1.32

6.80

2.3

2.1

7.70

7.56

g/l

0.86

368

2762

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

428

3188

1.32

6.76

2.3

2.2

3.75

3.67

g/l

0.42

367

2756

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

429

3197

1.32

6.75

2.3

2.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

412

1.89

6.71

1.2

—

(3000012) Reticulocyte production index

191

1246

1.50

6.55

1.9

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

478

3631

1.29

6.54

1.7

1.4

—

(3017732) Neutrophils [#/volume] in Blood

482

3669

1.29

6.50

3.3

3.4

6.07

5.72

e9/l

0.14

309

2634

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

610

4782

1.26

6.47

3.2

2.9

51.38

56.79

ml/min/173m2

5.06

304

2180

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

763

6132

1.23

6.46

2.0

0.20

g/l

0.69

696

5617

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

117

683

1.67

6.45

1.5

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

290

2052

1.38

6.43

1.9

1.6

39.08

38.06

u/l

0.34

245

1696

(3009445) Proteinase 3 Ab [Units/volume] in Serum

363

2661

1.34

6.42

1.8

1.5

25.35

22.00

u/ml

0.12

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

404

3011

1.32

6.37

2.4

2.1

10.42

10.21

g/l

0.36

339

2548

(3015235) Bicarbonate [Moles/volume] in Capillary blood

281

1988

1.38

6.24

3.0

24.55

25.12

mmol/l

1.37

270

1943

(3014051) Protein [Presence] in Urine by Test strip

255

1775

1.41

6.23

3.3

2.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

171

1105

1.51

6.16

3.0

2.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

286

2035

1.38

6.14

1.6

121.67

283.38

titre

1.42

102

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

353

2597

1.33

6.11

2.1

518.74

577.23

ug/l

0.22

338

2446

(3000494) Fungus identified in Specimen by Culture

783

6349

1.22

6.08

1.5

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

224

1536

1.43

5.98

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

307

2223

1.35

5.92

5.5

5.3

1.36

1.38

mmol/l

0.17

275

1965

(3000492) Spirometry study

513

3986

1.27

5.89

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

497

3849

1.27

5.86

7.2

8.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

199

1341

1.45

5.84

1.5

—

(3037756) Immunofixation for Serum or Plasma

254

1789

1.39

5.82

1.4

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

2952

1.30

5.53

2.5

2.2

3.08

3.02

g/l

0.54

327

2512

(3021901) Oxygen saturation in Capillary blood

217

1506

1.41

5.45

2.7

2.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

112

681

1.60

5.33

2.1

2.5

2.50

2.21

u/field

0.16

219

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

395

1.80

5.33

1.3

1.2

1.22

1.49

nmol/l

1.95

350

(40768443) Skin Pathology biopsy report

377

2856

1.29

5.33

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

553

4391

1.24

5.27

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

320

2392

1.31

5.01

4.7

5.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

406

1.75

4.89

1.9

2.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

150

993

1.47

4.89

2.0

2.1

32.21

32.41

0.22

145

984

(3017569) Oxygen content in Arterial blood

392

1.76

4.88

2.1

2.2

—

(3037121) Protein [Mass/volume] in Urine

325

2447

1.30

4.84

2.5

2.7

0.29

0.30

g/l

0.03

124

908

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

498

3950

1.24

4.82

6.6

7.2

24.47

24.46

mmol/l

0.01

470

3736

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

374

2876

1.27

4.73

3.4

3.1

4.32

4.28

pmol/l

0.34

320

2450

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

948

8002

1.17

4.69

3.3

3.7

21.23

21.81

ug/l

0.02

776

6650

(3052851) Hemolysis interference index of Serum or Plasma

301

2261

1.30

4.58

3.9

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

144

963

1.46

4.50

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

228

1.96

4.45

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

123

799

1.50

4.44

3.2

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

252

1856

1.33

4.43

1.5

1.4

251.91

268.07

ug/g

0.62

146

1134

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

175

1223

1.40

4.31

1.3

1.2

21.11

48.56

u/ml

1.25

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

166

1150

1.41

4.30

1.3

1.2

3.89

5.39

u/ml

0.60

192

(3006184) Hemoglobin [Mass/volume] in Capillary blood

239

1758

1.33

4.26

2.2

125.23

125.21

g/l

0.00

179

1283

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

164

1136

1.41

4.25

1.3

1.2

21.77

4.94

u/ml

0.41

120

(3024928) Oxygen saturation in Venous blood

201

1441

1.36

4.24

2.9

2.3

—

(4146454) Self-monitoring of blood glucose

115

746

1.50

4.20

2.7

2.5

—

(3051593) INR in Capillary blood by Coagulation assay

465

1.63

4.12

9.7

12.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

271

2041

1.30

4.09

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

2.87

4.04

6.6

4.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

183

2.02

4.01

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

138

938

1.43

4.00

1.5

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

138

938

1.43

4.00

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

300

2298

1.28

3.98

1.3

1.2

—

(3024471) HLA-A [Type]

2.75

3.98

1.1

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

231

1710

1.32

3.96

1.3

1.2

1.38

1.04

u/ml

0.18

170

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

133

902

1.44

3.91

1.6

1.3

0.83

0.82

nmol/l

0.02

113

738

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

140

2.15

3.87

1.7

1.5

192.83

123.79

ng/l

0.95

140

(3019977) pH of Arterial blood

443

1.63

3.86

2.2

2.5

7.43

7.42

0.02

167

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

345

2706

1.25

3.76

2.6

2.3

1.40

1.09

g/l

0.58

278

2220

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

322

2506

1.26

3.76

2.5

2.1

36.84

36.88

g/l

0.03

258

2059

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

200

1463

1.33

3.75

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

547

4496

1.19

3.75

1.5

—

(3024932) HLA-DR beta [Type]

2.73

3.72

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

399

3184

1.23

3.71

1.4

1.5

1.63

1.62

0.09

319

2548

(3045424) Erythrocytes [Presence] in Urine

140

971

1.41

3.66

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

223

1663

1.31

3.66

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

224

1672

1.31

3.65

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

245

1852

1.29

3.64

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

245

1852

1.29

3.64

1.4

—

(3048879) Bone marrow aspiration report

253

1.81

3.61

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

184

1338

1.34

3.60

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

796

1.44

3.60

4.1

—

(3039000) Anion gap in Blood

214

1591

1.31

3.60

6.2

5.9

11.25

11.32

mmol/l

0.13

200

1403

(3018572) Chloride [Moles/volume] in Blood

214

1591

1.31

3.60

6.2

5.9

105.18

104.83

mmol/l

0.48

200

1403

(40768800) Prostate Pathology biopsy report

187

1364

1.34

3.59

1.2

—

(3042631) Mycobacterium sp identified in Specimen

152

1074

1.38

3.57

2.3

2.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

251

1908

1.28

3.57

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

370

1.66

3.57

1.9

2.1

2.07

1.88

u/field

0.12

241

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.46

3.55

9.3

13.1

5.21

5.25

mmol/l

0.04

(3020961) Endomysium IgA Ab [Titer] in Serum

238

1806

1.29

3.45

1.1

69.38

248.83

titre

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

106

709

1.46

3.40

1.5

1.2

—

(3006462) Nitrate [Presence] in Urine

331

1.67

3.39

4.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

105

702

1.46

3.38

3.6

2.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

140

986

1.38

3.38

1.3

1.2

4.14

6.90

u/ml

0.43

(3039162) Centromere protein B Ab [Units/volume] in Serum

537

1.52

3.37

1.4

1.2

14.07

55.90

u/ml

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

856

1.41

3.36

1.3

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

144

1020

1.38

3.36

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

561

1.51

3.35

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

124

857

1.41

3.34

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

119

818

1.42

3.31

1.4

1.2

22.34

52.28

u/ml

2.48

(3005988) Vibrio sp identified in Specimen by Organism specific culture

124

859

1.41

3.31

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

268

1.74

3.29

1.4

1.3

0.98

1.21

nmol/l

1.09

202

(3013139) Helicobacter pylori Ag [Presence] in Stool

434

3538

1.20

3.29

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

110

747

1.43

3.28

3.1

3.4

59.04

57.66

0.24

606

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

110

747

1.43

3.28

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

134

943

1.38

3.26

1.5

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

142

1009

1.37

3.26

1.3

1.2

9.57

0.61

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

110

748

1.43

3.26

1.4

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

366

1.62

3.22

5.0

4.9

205.13

107.20

u/ml

0.37

111

(3014765) Yersinia sp identified in Stool by Organism specific culture

222

1687

1.28

3.21

1.3

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

125

874

1.39

3.17

7.1

5.8

13.09

12.62

mg/l

0.44

116

774

(42529406) Shigella sp [Presence] in Stool by Culture

222

1690

1.28

3.17

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

198

1486

1.30

3.15

2.8

301.42

716.19

u/ml

1.03

181

1337

(3003181) Sodium [Moles/volume] in Urine

200

1505

1.30

3.13

1.3

60.71

60.41

mmol/l

0.04

150

1209

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

237

1825

1.27

3.09

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

177

1314

1.31

3.06

2.1

1.6

14.83

12.61

mg/l

0.37

157

1175

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

191

1435

1.30

3.03

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

122

857

1.39

3.03

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

292

1.66

2.96

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

653

1.43

2.88

1.2

67.65

64.68

u/l

0.15

577

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

150

1101

1.33

2.84

1.8

1.6

5.77

4.46

iu/l

0.50

314

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

237

1.72

2.83

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

387

1.56

2.82

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

123

880

1.36

2.77

1.3

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

274

2176

1.23

2.76

2.6

2.2

0.01

0.00

g/l

0.63

246

1921

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

684

1.41

2.74

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

181

1371

1.29

2.74

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

637

1.42

2.71

1.6

1.3

265612.62

195711.16

e6/l

0.27

433

(4035726) Immunohistochemistry procedure

656

5623

1.14

2.70

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

290

2323

1.22

2.70

2.6

2.2

0.21

0.03

g/l

0.87

262

2061

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

128

930

1.34

2.62

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

363

2981

1.19

2.60

2.5

2.6

0.33

0.36

u/ml

0.72

208

1699

(3024522) Salmonella sp identified in Specimen by Organism specific culture

120

865

1.35

2.60

1.3

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

222

1.71

2.57

1.7

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

222

1.71

2.57

1.8

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

105

743

1.38

2.56

1.2

1.3

0.73

0.69

nmol/l

0.47

712

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

743

1.38

2.56

1.2

1.3

0.14

0.26

nmol/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

604

1.42

2.56

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

245

1.67

2.54

2.4

2.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

201

1562

1.25

2.50

4.3

3.9

28.26

30.22

mg/l

0.32

145

1049

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

323

1.56

2.46

1.1

24.79

32.43

u/l

0.70

285

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

323

1.56

2.46

1.1

87.52

90.76

u/l

0.13

286

(3044927) Protein electrophoresis panel - Urine

122

890

1.33

2.46

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

266

2136

1.21

2.45

2.7

2.2

0.00

g/l

-0.00

246

1912

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

186

1437

1.26

2.44

1.2

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

610

1.40

2.43

1.3

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

610

1.40

2.43

1.3

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

279

1.60

2.41

5.8

6.0

—

(3000285) Sodium [Moles/volume] in Blood

113

1.98

2.41

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

444

1.47

2.37

1.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

192

1.72

2.33

1.4

1.5

90.15

87.86

umol/l

0.04

114

(3027456) Digoxin [Moles/volume] in Serum or Plasma

311

2548

1.19

2.33

3.2

3.3

0.82

nmol/l

0.04

238

1974

(3024980) IgG subclass 4 [Mass/volume] in Serum

658

1.38

2.30

1.4

1.6

0.98

0.81

g/l

0.29

505

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

164

1.78

2.30

1.2

1.1

1.04

1.07

ratio

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

164

1.78

2.30

1.2

1.88

1.37

mmol/l

0.72

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

122

1.91

2.30

1.2

1.0

—

(3023419) Bacteria identified in Sputum by Culture

142

1070

1.29

2.30

2.5

2.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

712

1.35

2.22

1.8

1.7

23.67

26.67

u/ml

0.34

159

(3006442) Creatine [Moles/volume] in Serum or Plasma

340

1.52

2.21

1.7

93.89

94.35

umol/l

0.03

340

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

614

1.38

2.20

1.3

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

148

1129

1.28

2.19

1.3

48.23

42.65

u/l

0.23

121

967

(3020876) Protein [Mass/time] in 24 hour Urine

108

790

1.33

2.18

2.1

2.2

1.41

1.12

g/24h

0.53

350

(3023420) DNA double strand Ab [Units/volume] in Serum

453

1.44

2.16

1.4

1.2

28.60

23.80

iu/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

125

1.86

2.15

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

625

1.37

2.15

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

265

1.58

2.14

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

112

826

1.32

2.14

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

158

1219

1.26

2.14

3.4

3.5

1.40

1.50

0.14

129

1043

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

177

1384

1.25

2.14

3.3

2.4

1.92

1.83

mg/l

0.60

149

1190

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

177

1385

1.24

2.13

1.7

1.4

0.24

0.23

g/l

0.26

165

1287

(3014271) Vancomycin [Susceptibility]

635

1.36

2.12

3.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

126

947

1.29

2.11

17.2

8.0

7.58

7.37

mmol/l

0.33

101

769

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

259

1.58

2.09

3.0

2.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

329

1.51

2.09

1.9

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

181

1424

1.24

2.08

1.7

1.4

1.14

1.15

g/l

0.15

171

1323

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

354

1.48

2.05

2.4

2.2

52.50

75.89

ug/min

0.47

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

557

1.38

2.04

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

557

1.38

2.04

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

557

1.38

2.04

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

416

3533

1.15

2.02

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

186

1.67

2.02

1.4

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

285

1.53

2.01

1.1

1.2

1.12

1.00

promille

0.22

213

(3028192) IgG subclass 2 [Mass/volume] in Serum

412

1.44

2.00

1.2

1.4

2.75

2.85

g/l

0.13

304

(3024139) IgG subclass 3 [Mass/volume] in Serum

412

1.44

2.00

1.2

1.4

0.44

0.47

g/l

0.11

304

(3027135) IgG subclass 1 [Mass/volume] in Serum

412

1.44

2.00

1.2

1.4

6.98

7.05

g/l

0.05

299

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

388

1.45

2.00

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

388

1.45

2.00

1.3

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

650

1.35

2.00

1.2

1.3

—

nmol/l

—

(3036489) Thrombin time

237

1925

1.20

2.00

1.9

1.8

23.13

21.97

0.54

212

1762

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

309

1.51

2.00

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

445

1.42

1.99

2.3

2.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

123

930

1.29

1.98

1.9

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

115

1.86

1.97

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

561

1.37

1.96

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

611

1.35

1.96

1.7

1.2

105.36

122.08

u/ml

0.83

128

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

183

1454

1.23

1.94

2.3

2.2

3.66

3.60

g/l

0.21

173

1365

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.94

27.3

7.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

288

1.52

1.93

1.2

435.84

276.43

u/l

0.31

273

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.07

1.93

4.3

5.7

—

(3044007) Cell count panel - Peritoneal fluid

184

0.42

1.91

3.6

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.43

1.88

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

190

1.64

1.88

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

111

835

1.29

1.88

1.6

1.5

66.24

62.78

0.54

521

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

330

1.47

1.87

1.9

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

1096

1.25

1.84

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

594

1.34

1.82

3.4

3.0

53.50

28.24

mg/l

1.17

441

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.04

1.77

80.4

8.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

147

1154

1.24

1.77

1.6

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

263

1.51

1.77

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

106

1.83

1.74

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

218

1.56

1.72

1.3

1.2

6.19

6.29

mmol/l

0.14

203

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

385

1.41

1.72

1.2

84.29

136.00

titre

—

(3035880) pH of Pleural fluid

517

1.35

1.71

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

122

1.75

1.67

24.6

7.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

115

1.77

1.66

1.1

1.2

25.93

368.03

u/l

0.61

(3022493) Free Hemoglobin [Mass/volume] in Plasma

283

1.48

1.66

3.0

132.37

68.02

mg/l

0.61

187

(3033705) Calcium.ionized [Moles/volume] in Venous blood

159

1273

1.22

1.62

2.3

2.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

102

1.81

1.61

2.5

2.9

0.26

0.57

u/field

1.24

102

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

175

1416

1.20

1.60

1.7

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

424

1.38

1.59

1.2

1.3

—

(21494755) Public health laboratory ask at order entry panel

563

0.69

1.59

1.2

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

325

2768

1.14

1.58

2.0

11.28

10.65

nmol/l

0.54

266

2320

(3045142) Bone marrow Pathology biopsy report

728

1.28

1.58

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

575

1.32

1.58

1.0

1.1

78.96

825.32

iu/ml

0.80

(3011335) Digoxin [Mass/volume] in Serum or Plasma

110

1.77

1.57

3.0

2.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.31

1.57

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

154

1237

1.21

1.53

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

123

965

1.24

1.53

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

267

2249

1.16

1.53

1.2

1.3

238.03

232.15

u/ml

0.04

242

2028

(4034850) Laboratory test

233

1948

1.16

1.48

15.4

13.2

—

(3024263) Appearance of Synovial fluid

356

1.39

1.47

1.5

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

464

1.34

1.47

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

407

1.36

1.45

3.5

3.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

126

999

1.23

1.44

1.3

1.4

—

(4062490) Immunoglobulin typing, IgG

416

1.35

1.43

1.2

1.4

—

(3051651) Icteric interference index of Serum or Plasma

416

1.35

1.43

2.9

3.5

—

(44813793) Dust mix specific IgE antibody measurement

229

1.48

1.43

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

199

1651

1.17

1.41

1.8

1.6

14276.87

16168.05

e6/l

0.34

146

1159

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

255

1.45

1.38

2.0

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

255

1.45

1.38

2.0

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

114

900

1.23

1.37

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

161

1.57

1.36

1.6

2.2

7.29

7.39

mmol/l

0.06

113

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

280

1.42

1.36

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

624

1.28

1.35

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

146

1.60

1.35

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

185

1.52

1.34

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

566

1.29

1.33

1.3

1.1

311.82

299.74

u/ml

0.12

330

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.97

1.32

1.1

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

134

1082

1.20

1.31

1.1

33.88

15.88

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

258

1.43

1.31

1.3

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

122

977

1.21

1.30

1.7

4.06

4.47

mmol/24h

0.69

799

(3048929) Epstein Barr virus Ab [Presence] in Serum

767

1.24

1.29

1.3

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

219

1.46

1.28

1.6

2.1

894.64

2112.61

u/ml

2.29

212

(3034274) Bile acid [Moles/volume] in Serum --fasting

219

1.46

1.28

1.2

1.3

9.44

10.81

umol/l

0.17

147

(3020491) Glucose [Moles/volume] in Blood

425

1.33

1.28

2.8

2.4

7.48

7.11

mmol/l

0.43

289

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

459

1.31

1.27

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

140

1139

1.20

1.27

3.5

3.4

60.11

59.29

0.31

140

1139

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

260

1.42

1.26

2.1

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

111

885

1.22

1.25

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

197

1656

1.16

1.22

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

135

1.58

1.21

1.0

1.2

207.13

280.00

pmol/l

0.92

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

387

1.33

1.21

1.3

1.5

7.74

6.96

u/l

0.18

307

(3051101) Glucose [Moles/volume] in Cord blood

151

1.54

1.20

6.0

5.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

916

1.21

1.20

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

290

0.63

1.18

1.2

1.3

632.49

347.74

ug/l

—

154

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.55

1.17

1.2

1.9

—

(40768441) Liver Pathology biopsy report

331

1.35

1.16

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

137

1.56

1.15

2.3

2.0

2.47

3.81

ug/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

241

1.41

1.14

1.2

41.34

39.70

g/l

0.27

112

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

268

1.38

1.10

1.7

1.9

592.52

511.83

e6/l

0.29

228

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.82

1.08

1.1

1.0

—

(3022689) Creatine [Moles/volume] in Urine

132

1.54

1.07

1.9

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

140

1161

1.17

1.06

1.1

70.00

125.57

titre

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

380

1.30

1.04

1.3

1.2

97.00

90.04

u/l

0.24

326

(3023183) Ammonium ion [Moles/volume] in Plasma

149

1245

1.16

1.04

1.8

2.0

29.35

31.79

umol/l

0.97

120

1070

(3032057) Clostridioides difficile [Presence] in Stool

197

1.43

1.04

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

110

1.59

1.03

1.1

89.15

87.26

0.12

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

206

1.41

1.02

2.3

2.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

103

1.60

1.01

38.0

27.6

7.02

6.88

ug/l

0.09

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

174

1.45

1.01

1.7

1.4

18.76

17.03

pmol/l

0.81

132

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

207

1.41

1.00

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

366

1.30

1.00

1.3

1.2

32.63

28.00

u/l

0.17

304

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.20

0.99

3.6

3.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

600

1.23

0.99

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.82

0.97

2.0

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

112

1.56

0.97

1.1

—

(3016038) Potassium [Moles/volume] in Urine

549

1.24

0.97

1.1

34.40

34.65

mmol/l

0.03

449

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

411

1.28

0.96

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.52

0.96

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

161

1364

1.15

0.95

2.1

2.0

88.99

87.38

0.45

153

1300

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

412

1.27

0.95

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

132

1103

1.16

0.94

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

112

924

1.18

0.94

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

968

0.83

0.94

1.3

1.2

3.94

3.88

mmol/l

0.20

890

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.68

0.93

1.1

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.75

0.93

1.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

170

1.43

0.91

1.1

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

130

1.49

0.91

1.4

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

130

1.49

0.91

1.4

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

130

1.49

0.91

1.4

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

130

1.49

0.91

1.4

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

270

2371

1.11

0.90

1.1

1.2

131.88

127.23

iu/ml

0.05

768

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.66

0.89

7.9

7.3

—

(40757373) Influenza virus identified in Isolate

179

1.41

0.89

1.2

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

139

1.47

0.88

1.6

1.4

0.11

0.13

nmol/l

0.50

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.89

0.88

1.1

—

(3012565) Volume of 24 hour Urine

280

1.32

0.87

2.0

2.3

1791.94

1818.24

0.07

226

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

300

2655

1.10

0.87

1.3

47.23

62.75

au/ml

0.79

143

(21494890) Protein electrophoresis panel - 24 hour Urine

100

824

1.18

0.87

1.7

1.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

272

1.32

0.87

1.4

1.3

3.79

0.81

u/ml

0.63

160

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

230

1.35

0.87

1.2

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

444

1.25

0.86

1.2

—

59.89

—

(37021550) Renin [Units/volume] in Plasma --upright

124

1.49

0.85

1.1

1.3

29.09

78.31

mu/l

2.35

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

334

2976

1.09

0.85

2.5

2.4

14.03

24.20

au/ml

0.76

123

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

257

1.32

0.83

2.2

2.5

34.84

36.51

0.17

151

(3003434) Protein [Mass/volume] in Pleural fluid

157

1345

1.13

0.82

1.4

1.5

30.12

30.89

g/l

0.34

136

1179

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.69

0.82

1.0

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

139

1182

1.14

0.82

1.1

1104.00

1016.76

titre

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

474

1.23

0.81

1.5

—

(3033799) Differential panel - Peritoneal fluid

207

0.66

0.81

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

264

0.70

0.81

1.1

—

(3006270) Folate [Moles/volume] in Blood

687

1.19

0.81

1.3

1.2

304.92

313.31

nmol/l

0.15

503

(3009871) Measles virus Ab [Titer] in Serum

1.73

0.80

1.5

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.73

0.80

1.3

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

192

1.36

0.79

1.3

1.4

—

(3044941) Cell count panel - Synovial fluid

127

1077

1.15

0.78

1.6

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

486

1.22

0.78

1.3

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

107

897

1.16

0.77

1.2

1.3

519.18

379.84

u/l

0.34

100

842

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.65

0.77

1.0

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

647

1.19

0.76

1.7

1.5

20.72

27.56

1.59

409

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.76

0.76

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

108

909

1.15

0.75

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

112

1.47

0.75

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

112

1.47

0.75

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

104

1.49

0.75

2.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

729

1.17

0.75

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

202

0.67

0.74

3.3

1.9

64.07

48.72

u/l

0.16

187

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

952

0.85

0.73

1.5

1.3

137.61

27.80

e6/l

0.39

741

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

952

0.85

0.73

1.6

1.4

690.33

1067.29

e6/l

0.47

784

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

623

1.18

0.73

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

605

0.82

0.73

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

298

1.27

0.72

1.1

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

1.48

0.72

1.1

—

(3004775) Volume in Urine collected for unspecified duration

544

1.20

0.72

2.5

2.1

572.46

636.56

0.98

349

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

109

922

1.15

0.72

4.9

3.7

263.89

3506.71

iu/ml

0.95

129

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.74

0.71

4.1

4.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.70

0.69

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

663

1.17

0.69

1.2

1.3

328.21

264.87

pmol/l

0.75

551

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

139

1.40

0.69

1.1

—

9.13

u/ml

—

(3026470) Cobalt [Mass/volume] in Blood

512

1.19

0.68

2.0

1.9

5.08

4.01

ug/l

0.38

465

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.66

0.68

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.66

0.68

1.1

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

123

1.42

0.68

3.4

2.6

15.52

14.42

ml/dl

1.02

113

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.55

0.67

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

1.45

0.67

1.1

1490.69

1697.84

miu/ml

0.29

107

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

576

1.18

0.66

1.6

1.3

55.00

53.33

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

151

0.64

0.66

1.6

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

417

1.21

0.65

1.7

180.81

184.42

pmol/l

0.12

374

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

208

1.31

0.65

1.4

1.6

3.40

6.21

nmol/l

0.56

181

(3023199) Leukocytes [#/volume] in Pleural fluid

137

1187

1.12

0.65

1.3

1.5

5848.28

2129.59

e6/l

0.36

849

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

141

1.38

0.64

1.1

1.3

148.20

135.40

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

200

1.31

0.64

1.1

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

155

1354

1.11

0.64

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

124

0.63

0.64

9.3

8.2

13.70

13.69

—

124

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

424

0.80

0.63

1.1

1.0

624.60

660.03

ng/l

0.19

253

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

423

0.80

0.62

1.1

1.0

38.65

46.18

ng/l

0.59

257

(3013166) Neutrophils/100 leukocytes in Synovial fluid

227

1.28

0.62

1.8

1.3

72.91

60.07

1.38

195

(3002079) Sodium [Moles/time] in 24 hour Urine

202

1.30

0.61

1.1

1.2

140.89

147.57

mmol/24h

0.21

202

(3011412) CD3 cells [#/volume] in Blood

421

1.20

0.60

1.8

1.9

1.10

1.05

e9/l

0.18

382

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

421

0.81

0.60

1.1

1.0

275.45

335.46

ng/l

0.85

260

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

135

0.65

0.60

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.60

0.0

1.5

—

(3025577) Chromium [Mass/volume] in Blood

502

1.18

0.60

2.0

2.26

2.34

ug/l

0.05

416

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

529

1.17

0.60

1.7

1.6

5.73

4.73

mg/l

0.49

493

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

152

1.34

0.59

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.1

—

39.41

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

548

1.17

0.59

1.1

—

(3016750) Collection duration of Urine

370

1.21

0.58

2.1

2.0

516.15

498.31

min

0.78

268

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

703

1.15

0.57

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

204

1.28

0.57

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.71

0.57

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

596

1.16

0.56

1.6

1.3

56.36

308.77

titre

2.55

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

1081

1.11

0.55

1.3

1.5

92514.18

61111.72

e6/l

0.19

634

(3002619) Bacteria identified in Specimen by Culture

137

1.35

0.55

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

405

0.81

0.55

1.0

1.1

—

3.52

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

104

1.40

0.54

2.2

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

347

1.20

0.53

2.5

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

718

1.14

0.52

2.3

2.0

233.25

1856.65

u/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

1.53

0.52

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

519

1.16

0.52

1.2

2.92

4.10

u/ml

0.51

160

(3011648) Oxygen content in Venous blood

456

1.17

0.52

1.7

1.6

11.59

10.14

1.62

456

(1617658) Protocol used for examination of sentinel lymph nodes

439

1.17

0.51

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

666

1.14

0.50

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

350

1.19

0.50

3.1

3.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

113

1212

0.90

0.49

1.9

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

166

1.29

0.49

1.0

0.04

0.34

u/ml

2.07

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

369

1.18

0.49

1.2

1.1

242.95

165.27

miu/ml

0.38

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.51

0.48

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.51

0.48

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.51

0.48

1.4

1.0

—

(21494434) Karyotype in Bone marrow

633

1.13

0.47

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

542

1.15

0.47

1.8

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

537

4988

1.05

0.47

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.44

0.47

1.3

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

344

1.18

0.47

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

362

1.18

0.46

1.3

1.5

75.79

66.98

1.11

286

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

204

0.76

0.46

1.9

2.0

46.00

52.34

umol/l

0.38

161

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

507

1.15

0.46

1.2

4.53

4.61

u/ml

0.02

230

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

229

1.23

0.46

1.4

14.39

22.38

1.12

184

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

144

1282

1.09

0.46

2.6

2.2

219.78

214.34

0.30

138

1205

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

408

1.17

0.45

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

408

1.17

0.45

1.3

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.41

0.45

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

581

1.14

0.45

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

137

0.71

0.45

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

100

1.36

0.44

1.1

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

126

1.31

0.43

2.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

125

0.70

0.43

1.0

1.1

—

(3017704) Immunofixation for Urine

438

1.15

0.43

1.6

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.39

0.43

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

118

1.32

0.42

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

318

0.82

0.42

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

612

1.13

0.42

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

179

1.25

0.42

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

457

1.15

0.42

1.2

8.68

8.03

mmol/l

0.53

355

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

135

0.72

0.42

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.34

0.40

1.4

1.0

—

(3028433) Virus identified in Specimen by Culture

189

1.23

0.40

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

287

1.18

0.40

1.9

2.0

578.90

611.99

e6/l

0.20

267

(3011985) Renin [Units/volume] in Plasma

716

1.11

0.40

1.1

1.3

64.15

50.10

mu/l

0.22

627

(3020650) Glucose [Presence] in Urine

111

1.31

0.39

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.39

0.39

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.39

0.39

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

225

1.21

0.39

3.0

5.5

74.68

69.64

0.70

177

(40768446) Kidney Pathology biopsy report

137

1.27

0.39

1.7

1.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.43

0.39

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.43

0.39

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

315

1.17

0.39

1.6

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

190

1.23

0.39

2.0

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

113

1006

1.09

0.38

1.4

162.06

277.10

pmol/l

2.37

106

965

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.39

0.38

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

1.39

0.38

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

103

916

1.09

0.36

1.4

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

185

0.79

0.36

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

743

0.90

0.36

1.8

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

427

1.14

0.36

1.9

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

574

1.12

0.36

1.7

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.65

0.35

18.0

9.7

1061.00

764.06

nmol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

863

1.09

0.35

1.4

6.54

6.34

mmol/l

0.26

793

(3012441) Differential panel - Pleural fluid

115

1031

1.08

0.35

1.3

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.39

0.35

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

264

2690

0.95

0.34

3.5

4.1

83.21

92.31

u/ml

0.15

247

2554

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

140

1.25

0.34

1.5

1.1

1.40

3.73

u/l

—

(3004451) EKG impression Narrative

394

1.13

0.32

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

159

1.22

0.32

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

186

1.20

0.32

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

195

1.19

0.32

1.2

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

195

1.19

0.32

1.0

1.1

6.57

12.39

iu/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

124

1.25

0.32

1.3

1.2

2.88

1.66

mmol/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

813

1.09

0.31

2.8

3.6

—

(3034426) Prothrombin time (PT)

107

1.27

0.31

1.1

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

169

1.21

0.31

1.4

1.3

24.69

31.36

0.55

111

(3036071) Salmonella sp Ab [Titer] in Serum

0.71

0.30

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.31

0.30

1.9

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.28

0.30

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

434

1.12

0.30

1.1

111.36

113.98

0.19

366

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

0.78

0.29

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

108

1.26

0.29

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

117

1.24

0.29

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.30

0.28

1.1

1.5

53.09

47.09

umol/l

0.27

(1002224) Polysomnography panel

837

1.08

0.28

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

292

0.86

0.27

1.8

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

281

1.14

0.27

1.1

0.45

0.86

u/ml

0.72

141

(3045683) HLA typing for celiac disease panel - Blood or Tissue

145

1.20

0.27

1.1

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

1.27

0.26

15.9

10.5

0.58

0.65

mmol/l

0.49

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

606

1.09

0.26

1.7

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.70

0.26

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

569

1.09

0.26

1.1

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

597

1.09

0.26

1.4

—

(40768806) Pleura Pathology biopsy report

112

1020

1.07

0.25

1.5

1.6

—

(3014891) Appearance of Pleural fluid

164

1.18

0.25

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

412

0.89

0.25

1.7

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.25

1.1

—

(4212803) Bone marrow aspirate examination

1.27

0.25

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

482

0.90

0.24

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.24

0.22

1.0

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

295

1.12

0.22

1.2

1.1

0.94

13.12

nmol/l

—

(3044290) Cell count panel - Cerebral spinal fluid

879

0.94

0.22

1.4

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3011288) Drugs identified in Urine by Screen method

0.78

0.21

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

1.20

0.21

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

464

1.09

0.21

1.1

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.20

0.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

105

965

1.06

0.20

1.6

1.7

16.64

23.68

ug/l

2.86

935

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

0.81

0.20

1.8

1.6

10.41

9.75

ug/l

—

119

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

119

0.81

0.20

1.0

1.3

1.49

1.57

g/l

—

119

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

222

0.87

0.19

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

222

0.87

0.19

1.0

—

(3001729) Color of Synovial fluid

1.24

0.19

2.7

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

114

1.19

0.19

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

326

1.10

0.19

2.1

2.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

169

1.15

0.19

1.7

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

523

1.08

0.19

1.4

1.3

10.46

13.08

u/l

0.87

412

(3020911) Cortisol [Moles/time] in 24 hour Urine

142

1.16

0.18

1.2

1.4

201.29

202.15

nmol/24h

0.00

142

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

281

0.90

0.18

1.9

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.20

0.18

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.09

0.17

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.09

0.17

1.4

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.13

0.17

1.1

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

158

0.86

0.17

1.0

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.72

0.17

3.8

2.4

—

117.71

ng/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.72

0.17

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

320

1.09

0.16

1.4

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

162

1.14

0.16

1.1

—

(3008898) HLA-B27 [Presence]

754

1.06

0.16

1.0

—

(3008295) Osmolality of Serum or Plasma

688

1.06

0.16

1.3

273.33

274.16

mosm/kgh2o

0.12

483

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

289

0.91

0.16

1.3

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

146

0.86

0.15

1.6

1.3

146.27

144.91

pmol/l

0.02

146

(3008401) Mugwort IgE Ab [Units/volume] in Serum

238

1.10

0.15

1.0

1.04

1.18

u/ml

0.08

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.14

1.5

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.82

0.14

1.4

1.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

124

0.86

0.13

1.2

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

123

0.87

0.12

1.0

0.25

1.36

u/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

706

1.04

0.11

3.7

3.6

307.10

330.59

umol/l

0.77

572

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

270

1.08

0.11

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

412

1.06

0.11

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

570

0.95

0.11

1.1

1.55

1.58

g/l

0.19

498

(3034891) Synovial lining cells/100 cells in Synovial fluid

322

0.93

0.11

1.5

1.4

5.00

3.40

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

318

1.07

0.11

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

318

1.07

0.11

1.4

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

337

1.06

0.11

1.1

—

(40768793) Breast Pathology biopsy report

136

1283

1.03

0.10

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.06

0.10

1.4

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.15

0.10

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

244

1.07

0.09

1.0

0.66

1.92

u/ml

1.38

100

(3050794) Legionella sp Ab [Presence] in Serum

1.03

0.09

1.4

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

387

1.05

0.09

1.0

1.1

12.77

3.48

u/ml

—

(3026726) Creatinine [Moles/volume] in Specimen

1.10

0.09

2.2

2.3

1315.17

568.13

umol/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

120

0.89

0.08

1.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

0.89

0.08

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

588

1.04

0.08

1.4

—

(4281824) Cell count and differential, peritoneal fluid

644

0.96

0.08

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.04

0.08

1.0

1.2

—

181.91

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

151

1.09

0.08

1.4

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

446

0.96

0.08

2.0

1.8

317.64

342.03

mu/l

0.15

410

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

149

0.91

0.07

1.9

2.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.86

0.07

1.2

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.08

0.07

1.1

2.0

—

(3016879) Cocaine [Presence] in Urine

133

1.09

0.07

1.1

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

171

1.08

0.07

1.6

1.5

0.47

0.39

ug/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.05

0.07

1.7

1.2

—

(3015183) Erythrocyte sedimentation rate

0.84

0.06

1.0

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

128

0.91

0.06

1.0

0.28

0.94

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

108

0.90

0.06

1.0

0.01

0.29

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

100

0.87

0.06

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

191

1.07

0.06

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

135

1.08

0.05

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

275

2640

1.01

0.05

2.4

2.9

301.62

1836.32

u/ml

2.16

222

2208

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

185

0.94

0.04

1.3

—

(3028300) Cannabinoids [Presence] in Urine

136

1.07

0.04

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

146

1.06

0.03

2.0

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

839

1.02

0.03

1.6

1.5

2.89

3.40

mg/l

0.28

650

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

173

0.95

0.02

1.1

1.09

1.16

u/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

824

1.01

0.02

1.3

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

211

0.97

0.02

1.2

1.1

319.33

296.47

mg/l

0.29

184

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

211

0.97

0.02

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

240

0.97

0.01

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

216

1.03

0.01

1.4

1.2

—

(3027944) Amphetamines [Presence] in Urine

130

1.04

0.00

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

421

1.01

0.00

1.4

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

169

1.03

0.00

1.2

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

101

0.96

0.00

1.3

1.6

1.18

1.25

ug/l

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

101

0.96

0.00

5.7

3.8

38.90

58.74

u/l

—

(3000764) Benzodiazepines [Presence] in Urine

133

1.02

0.00

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

160

1.03

0.00

1.4

1.5

15.86

7.30

—

(3016018) Differential panel - Cerebral spinal fluid

431

0.99

0.00

1.7

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

457

1.00

0.00

3.3

2.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

703

0.99

0.00

1.2

1.3

12.32

12.99

u/l

0.18

634

(3047189) Immunofixation for 24 hour Urine

354

0.99

0.00

1.6

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

279

1.01

0.00

1.9

1.4

5.05

6.43

u/l

1.00

227

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

509

1.01

0.00

1.6

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

189

0.97

0.00

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

132

1276

1.00

0.00

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

0.85

0.00

1.8

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.84

-0.00

1.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

2.72

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

1.61

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.94

-0.00

1.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.99

-0.00

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.96

-0.00

2.0

1.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.8

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

307.40

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

6.20

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.95

-0.00

1.2

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.95

-0.00

8.5

12.8

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.01

-0.00

1.0

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint WET_AMD and mortality.

Females

Parameter	HR [95% CI]	p-value
WET_AMD	0.833 [0.76, 0.91]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.306

During the follow-up period (1.1.1998 — 31.12.2019), 11318 out of 30853 females with WET_AMD died.

Males

Parameter	HR [95% CI]	p-value
WET_AMD	0.905 [0.81, 1.01]	0.064
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 6694 out of 16881 males with WET_AMD died.

Mortality risk

Mortality risk for people of age

years, who have WET_AMD.

N-year risk	Females	Males
1	0.084%	0.179%
5	0.505%	0.921%
10	1.256%	2.546%
15	2.328%	4.81%
20	4.171%	8.311%

Relationships between endpoints

↥

Index endpoint: WET_AMD – Wet age-related macular degeneration

GWS hits: 29

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Wet age-related macular degeneration

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints